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71. Introduction
As soon as infant in the womb is born, natural colonization of the microbiota takes place
through contacts with mother’s vagina, excreta and skin (Funkhouser and Bordenstein 2013;
Mahony et al. 2018). These environmental exposures are the foundation for establishing a
symbiotic microbial community, which matures during childhood and from that on remains
relatively stable (Trasande et al. 2013). Microbiome and microbiota are the two terms used to
address the host-associated microbial communities. The term microbiome was first coined by
Joshua Lederberg in 2001 (Lederberg and McCray 2001), since then it has become popular
among researchers. Although strictly speaking the term microbiota refers to microbial species
living on or in human body and microbiome additionally to the complete set of their genes,
presently these terms are used interchangeably (Turnbaugh et al. 2007).
Microbial cells outnumber the total cells in human body, most of them residing in the
gastrointestinal tract (Ursell et al. 2012; Sender, Fuchs, and Milo 2016) from where they
contribute to key physiological processes, such as digestion, immunological maturation and
modulation and even behaviour (Sekirov et al. 2010; Qin et al. 2010; Ursell et al. 2012; Cox et
al. 2014; Tanaka and Nakayama 2017). Hence, scientists are now focused in defining the
symbiotic relationship of human and the microbiota (NIH HMP Working Group et al. 2009).
Accumulating evidence indicates that a child’s healthy future is dependable on early
colonization and its effects on immunological and other physiological programming (Fisher et
al. 2017; Jenmalm 2017), and the factors driving early microbiota development and the
resultant influences on child’s health are being studied extensively (Mueller et al. 2015a).
Numerous factors are responsible for shaping the human microbiota starting from the mode of
birth (Rodríguez et al. 2015). The two to five first years of life is the most critical period to
establish a healthy microbiota towards an adult-like composition  (Koenig et al. 2011;
Yatsunenko et al. 2012; Borre et al. 2014);  disruption in natural microbial colonization and
succession can lead to increased risk of chronic diseases later in life (Rodríguez et al. 2015;
Funkhouser and Bordenstein 2013; Rautava 2017).
The intestinal microbiota acts as a physical barrier against pathogenic microbes and perform
some of the important metabolic activities, such as digestion and nutrient metabolism (mostly
enzymatic) and drug metabolism. Our immune system can develop tolerance and function
appropriately from the beginning and throughout the lifetime with the help of microbes residing
8in our gut (Jandhyala et al. 2015). An enormous firewall system is responsible in maintaining
homeostatic relationship between the microbes and the host, and breakdown in this
homeostasis can result in several inflammatory conditions and diseases (Macpherson et al.
2009; Belkaid and Hand 2014; Isolauri, Sherman, and Walker 2017; Fung, Olson, and Hsiao
2017; Rowland et al. 2017; Tanca et al. 2017).
Feces is the most feasible and popular material to study the gut microbiota, representing the
microbial population residing in the lower gastrointestinal tract (Matsuki et al. 2002). Culture-
dependent techniques are not suitable for large-scale microbiota studies due to their selection
bias and labour-intensity. Molecular, culture-independent techniques are popular nowadays as
they can successfully address these problems and can be adjusted to fulfil the required criteria
(Hiergeist et al. 2015). Next Generation Sequencing (NGS) is currently the most popular
approach for high throughput microbiota analysis, typically based on the amplification and
sequencing of the 16S rRNA gene (Eckburg et al. 2005; Schuster 2008; Wang et al. 2009;
Jandhyala et al. 2015; Walker et al. 2015). NGS has successfully replaced culture-dependent
(Suau et al. 1999; Rajilić-Stojanović and de Vos 2014) old methods and when compared to
Sanger sequencing, this technique provides massive parallel sequencing in a cost-effective way
(Sanger, Nicklen, and Coulson 1977; Behjati and Tarpey 2013). Following the first large scale
microbiome projects,  the US Human Microbiome Project (HMP) and European Metagenomics
of the Human Intestinal Tract (MetaHIT) (Qin et al. 2010; Human Microbiome Project
Consortium 2012), the number and volume of human gut microbiota studies have increased
exponentially with recent studies analysing up to thousands of samples (Beaumont et al. 2016;
Falony et al. 2016). Hence there is an increasing need for efficient HTP sample processing
methods for molecular microbiota analyses based on fecal samples. An efficient fecal sample
processing system requires an appropriate sample handling protocol and a robust and efficient
DNA extraction method. Mechanical lysis of the cells has been shown to be essential for
efficient lysis of both gram positive and negative bacteria to gain a good representation of the
full diversity and species composition of the gut microbiota (Salonen et al. 2010; Smith et al.
2011; Claassen et al. 2013; Walker et al. 2015).
In this MSc thesis a new high throughput system was tested and validated for extracting
bacterial DNA from 96 fecal samples per run. The protocol was optimized for simple and
complex bacterial communities from infants and adults, respectively. With this new system,
based on the Repeated Bead Beating (RBB) and automatic purification methods, large number
of samples can be processed in short period without compromising the efficiency of cell lysis.
9The high throughput system was further optimized to improve both the quantity and quality of
microbial DNA using self- made buffers for lysis, washing and elution instead of those
available in the extraction kit, to optimize the DNA preps for PCRs, sequencing and other
downstream experiments. Optimized high throughput system was then used to extract
microbial DNA from 634 fecal samples of mother-infant dyads, summing up to 342 adults and
292 infant samples, represent different time points since childbirth. A subset of the samples
was analysed with PCR and qPCR to quantify the probiotic Lactobacillus rhamnosus GG
(LGG) to determine its carriage rate as well as the age at which the infants became positive for
LGG. In addition, the prevalence of LGG was studied in 3-month-old children from two
different birth cohorts sampled ~10 years apart.
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2. Literature Review
2.1. Use of feces as study material
Fecal samples provide a non-invasive material for the analysis of the gastrointestinal,
predominantly colonic, microbes (Biasucci et al. 2008). The gastrointestinal microbiota
consists of up to hundred trillion bacteria, which significantly contribute to our health and well-
being by food digestion and nutrition intake, neutralizing pathogens, and shaping our immune
systems (Tappenden and Deutsch 2007; Belkaid and Hand 2014). Development of the human
microbiota throughout the lifetime, their functions and study approaches are being discussed
under this section.
Current intestinal microbiota studies are largely dependent on the fecal samples that can be
collected, stored and processed using different methods. Feces can unravel wide range of
information from individuals and colonic luminal microbial composition excluding the
mucosal layer and small intestine which require more invasive approach (Zoetendal et al. 2002;
Eckburg et al. 2005; Aguirre and Venema 2015). Comparatively, convenience in collecting
fecal samples without intricacies makes it very popular and useful method for studying the
human gut microbiota. Briefly, feces is composed of 75% water and 25% solid material (30%
deceased bacteria, 40% proteins, fat and inorganic substances and 30% undigested foods and
other components) (Barbosa 2013).
Collection, storage and processing of fecal samples especially for molecular studies have
always challenged researchers, as several factors comes in to play that can affect the outcome
of study (see next section). For an optimal high-throughput system, sample handling time
should be minimized whilst maintaining the quality of samples. Weighing the required amount
of sample is the most tedious work which takes half of the total processing time and eliminating
this step to process fecal samples for DNA extraction was our priority. Child fecal samples are
normally semi solid or watery and messy so it’s trickier to collect baby fecal samples compared
to adults. Thus, a standard fecal sample processing system is need for reproducible results.  A
new high throughput fecal sample processing system, starting from the collection of feces to
quantification of extracted DNA was developed in this project to enable efficient processing of
thousands of fecal samples for microbiota analysis.
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Large scale study designs where thousands of fecal samples need to be collected set special
requirements for sample collection, storage and transportation. All these steps have very
important role in preserving the original ratio of microorganisms in the sample because the
relative abundance of different bacteria is typically the main outcome of microbiota studies.
Immediate freezing is considered as the gold standard in sample collection and thawing should
be avoided before the DNA extraction (Tedjo et al. 2015; Costea et al. 2017). Shaw et al
reported that infant’s fecal samples represented original microbial community independent of
their storage at -80°C and method of DNA extraction (Shaw et al. 2016). Lauber et al’s study
also revealed no compositional microbiota differences between 3 days and 2 weeks old samples
stored at temperatures +20, +4, -20 and -80°C (Lauber et al. 2010). Finally, Tedjo et al’s study
also observed no significant differences among the total microbiota and number of species in
fecal samples stored at different temperatures, whether from healthy subjects or unhealthy
subjects (patients with Irritable Bowel Syndrome and Inflammatory Bowel Disease) and
independent of fecal consistency (Tedjo et al. 2015). Although these studies indicate that the
fecal microbiota composition is relatively stable during storage and the individual-specific
profiles are not overridden by technical factors, aliquoting and storing at -80°C while
eliminating thawing before first DNA extraction is considered as the best option to ensure that
technical variation does not mask the more nuanced microbiota differences that may be
important. These are also the recommendations of the FP7-funded International Human
Microbiome Standards (IHMS) project (http://www.microbiome-standards.org/) that was
established to develop standard operating procedures (SOPs) to optimize data quality and
comparability for the microbiota studies on human fecal material.
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2.2. Current methods used to study gut microbiota using fecal material
2.2.1. Microbial DNA extraction and purification
Modern human microbiome research is largely based on DNA extracted from fecal samples
and hence the quality of DNA is crucial for the success of experiments and their outcome.
DNA extraction methods have evolved drastically as compared to the traditional phenol-
chloroform method, which mainly focuses on removal of polymerase chain reaction (PCR)
inhibiting components, their carryover to the next step (McOrist, Jackson, and Bird 2002), and
importantly lacks throughput capability while also being unsafe. Traditional, time consuming
additional clean up procedures have made scientists to think about using the solid matrix
(silica) as a binding agent for the extracted DNA, which requires fewer washing steps to remove
the undesirable components (Boom et al. 1990) and has been proven very effective in microbial
DNA extraction from feces (Jones et al. 1993). Processing large number of samples using the
above two methods have proven laborious, time consuming and costly, so the development and
use of commercial kits has become popular. Several papers have compared different fecal DNA
extraction methods and have shown that successful DNA extraction is dependent on cell lysis
step which can rupture cell walls from both gram positive and negative bacteria as otherwise
the sample is not representative for all bacteria present in the sample  (Fujimoto, Nakagami,
and Kojima 2004; Salonen et al. 2010; Santiago et al. 2014; Costea et al. 2017). Based on these
studies. mechanical bead beating method has been shown to be efficient in rupturing the cell
walls, especially of gram positive bacteria.  The further steps for purification of the DNA
mainly affect the yield and purity as well as the time needed to complete the protocol (Salonen
et al. 2010). The RBB method that was used as a starting point in this MSc thesis is widely
used and has been shown to perform well in extracting DNA from a wide range of bacteria
found in fecal samples (Salonen et al. 2010; Costea et al. 2017, 1069).
As traditional methods can only handle limited number of samples at a time, researchers are
now interested in high throughput extraction and purification systems to conduct large scale
research.  These new high throughput methods should also be efficient in producing high
quality DNA, decrease the amount of labour and should be inexpensive. Traditional extraction
and purification methods require multiple centrifugation steps which has been the major hurdle
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for making the whole process automatic, to tackle this problem modern nucleic acid
purification systems use paramagnetic beads. Use of paramagnetic beads (Figure 1) with
modified surface capable of efficient DNA binding (and releasing by magnetic disconnection)
have become popular in delivering high quality nucleic acids with minimal use of washing
buffers (Lesley 2001; Akutsu et al. 2004). Use of magnetic beads for the separation enables
extraction of nucleic acids directly from crude samples (feces, blood, culture media,
homogenized tissues, etc.) whilst eliminating the carry-over of biological debris and the need
for extra laborious steps required to pre-process the samples. All these features make this
method well suited for high-throughput DNA extraction and sample processing (Šafařík,
Ptáčková, and Šafaříková 2001; Franzreb et al. 2006).
Figure 1 Illustration of basic principle of nucleic acid purification using paramagnetic beads
(figure adapted from Creative Diagnostics® and principle from Thermo Scientific™
KingFisher™)
2.2.2. Polymerase Chain Reaction (PCR)
PCR is a valuable tool for studying gene expression, identifying and quantifying pathogens,
and conducting clinical diagnostics including forensics. It has become a starting point of many
advanced molecular techniques and has been used extensively since its development
(Weissensteiner and others 2003). In a normal end-point PCR, oligonucleotide primers specific
to the targeted DNA is used to amplify the given DNA segment and the results are visualized
in agarose gel to evaluate the intensity and size of the amplicon(s). With many advantages,
end-point PCR lacks real time visualization and quantification of amplifications and there is
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always chances of getting false amplifications. However, end-point PCR is extensively used in
detection of various bacteria using ribosomal RNA (rRNA) or other bacterial genes as targets
from different sample types including feces (Picard et al. 1992; Matsuki et al. 2002; Wang et
al. 2009). For example, specific primers were used to amplify and detect Bifidobacteria and
Lactobacillus species from infants’ and adults’ fecal samples (Kok et al. 1996; Walter et al.
2001), and  sortase C gene-targeted end-point PCR was used to differentiate a specific probiotic
strain Lactobacillus rhamnosus GG (LGG) from other Lactobacillus strains and probiotic
bacteria (Vélez, De Keersmaecker, and Vanderleyden 2007; Kankainen et al. 2009; Call and
Klaenhammer 2013; Douillard et al. 2014; Rasinkangas et al. 2014).
2.2.3. Real Time PCR or quantitative PCR (qPCR)
Unlike the normal PCR, qPCR enables real time monitoring of nucleic acid amplification and
quantification of the products. Firstly introduced by Holland et al., it has been continuously
developing since and with the introduction of new fluorescent dyes this method has become
more sensitive and reliable in targeting and quantifying specific nucleic acids (Holland et al.
1991; Lee, Connell, and Bloch 1993; Heid et al. 1996; Wall and Edwards 2002). For human
microbiome research,  qPCR has been used extensively  for detection and quantification of
specific bacteria in fecal samples (Olsen et al. 1986; Vaughan et al. 1999; Blaut et al. 2002;
Matsuki et al. 2002; Wang et al. 2009; Sekirov et al. 2010; Walker et al. 2015) while more
recently the use of this targeted method has decreased due to the advanced sequencing
techniques providing  relative abundance of all detected bacteria. However, qPCR is still the
method of choice when absolute quantification of certain bacteria is desired. In this thesis
project, a new qPCR assay was developed to replace the end-point PCR on L. rhamnosus GG
sortase C gene that lacked the specific identification, quantification and throughput properties
needed to correctly identify and quantify this specific probiotic species in fecal samples.
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2.2.4.  Next Generation Sequencing (NGS)
NGS is a revolutionary technology that has modernised genomic research by enabling DNA
sequencing in high throughput mode. NGS possesses the capability of massive parallel
sequencing with unprecedented speed and accuracy, and have become the workhorse of human
microbiome studies (Sanger, Nicklen, and Coulson 1977; Schuster 2008; Pareek, Smoczynski,
and Tretyn 2011; Van Dijk et al. 2014; Reuter, Spacek, and Snyder 2015; Daliri et al. 2017;
Lyons et al. 2017).  Several NGS platforms are available and they use different sequencing
technologies (Behjati and Tarpey 2013). In microbiome studies, Illumina’s MiSeq and HiSeq
platforms are widely used, most typically for sequencing of the 16S rRNA gene amplicons that
provide information on bacterial composition and diversity after bioinformatic analysis.
2.3. Gut microbiota in infants and adults
Following birth, infant’s gut is colonized by diverse microorganisms. The first colonizers are
facultative anaerobes, such as Enterobacteriaceae and Bacilli, and within the following days
and weeks, anaerobic Bifidobacterium, Clostridium and Bacteroides start to dominate
(Matamoros et al. 2013). Bifidobacterium spp. are specialized in fermenting human milk
oligosachharides and thrive for the first few months especially in breast-fed babies. With the
introduction of solid foods their numbers start to decrease and Bacteroides, Ruminococcus and
Clostridium, specialized in metabolizing complex dietary polysaccharides take over (Koenig
et al. 2011; Bäckhed et al. 2015) and by the age of 2 to 3 the microbiota largely resembles that
of an adult. During child’s gut microbiota’s development period, extrinsic factors have more
effect on the development of gut microbiota than intrinsic factors (Fallani et al. 2010; Koenig
et al. 2011; Munyaka, Khafipour, and Ghia 2014). A recent study has also reported the
exceeding impacts of environmental factors over genetics in shaping the adult gut microbiota
(Rothschild et al. 2018).
In adulthood, the gut microbiota is remarkably stable and the subject-specific composition
persists at least for a decade, presumably longer (Rajilić-Stojanović et al. 2013). There are
substantial differences in microbial composition between individuals at species and genus
levels but practically always the dominant ones belong to Clostridium clusters XIVa and IV
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among Firmicutes or Bacteroides spp., reaching up to 60%-80% of total bacteria depending on
the individual (Hayashi, Sakamoto, and Benno 2002; Zhernakova et al. 2016; Lyons et al.
2017). Proteobacteria and Actinobacteria typically make up to 5%-10% of total bacteria
(Wang et al. 2003; Eckburg et al. 2005; Agans et al. 2011; Lay et al. 2005). Most adults (80%)
are positive for Lactobacillus but like the other facultative anaerobes, e.g. Eschericia coli,
Enterococci and staphylococci, they normally represent less than 1 percent of adult’s fecal
microbiota (Adlerberth and Wold 2009).
2.4. Factors affecting the development of infant’s gut microbiota
The microbial colonization starts at or after birth and children’s microbiota undergoes
succession with changes with the environmental and endogenous conditions (Stark and Lee
1982; Benno 1985; Mueller et al. 2015a; Rodríguez et al. 2015; Tanaka and Nakayama 2017).
There are several factors (Figure 2) that can affect the normal colonizing process in infants and
overall modify the microbiota (Guarner and Malagelada 2003; Funkhouser and Bordenstein
2013).
Figure 2 Factors that can affect infant’s gut microbiota development and influence the
microbiota overall.
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Several premature and term birth studies have suggested the presence of microorganisms
already in the placenta and meconium, which points out the scenario that infants may get first
introduced to microbes already inside the womb (Aagaard et al. 2014; Ardissone et al. 2014),
through placental barrier (Aagaard et al. 2014), through umbilical cord blood (Jiménez et al.
2005), through amniotic fluid (Bearfield et al. 2002) and fetal membrane (Rautava et al. 2012)
without development of any kind of inflammation or infection. Staphylococci, streptococci and
lactobacilli are the dominant bacteria in meconium (Moles et al. 2013; Hu et al. 2013).
The first week after the birth child’s microbiota is very similar to mother’s skin and vaginal
flora (Stark and Lee 1982; Koenig et al. 2011). The mode of delivery (vaginal vs. caesarean)
is regarded as one of the main factors shaping the early microbiota. The caesarean delivered
babies are lacking normal colonizing pattern, especially Bifidobacteria and Bacteroides spp.
for months when compared to vaginally delivered children (Bäckhed et al. 2015; Azad et al.
2016). Naturally delivered infants are first exposed to the bacterial species most prominent in
the vagina and feces of the mother rather than those born by caesarean method who lack these
maternal exposures (Biasucci et al. 2008).
Diet is one of the most influencing factors in shaping the human microflora throughout the
lifetime. Earliest dietary effects on the gut microbiota are  due to the introduction of mother’s
milk versus formula feeding, while later the intake of cereals, vegetables and other foods with
higher fiber content associate with the  microbiota composition and their diversity (Biasucci et
al. 2008; De Filippo et al. 2010; Walker et al. 2011). Human breast milk is the first and most
important food of an infant that among other benefits helps in the development and maturation
of the gut microbiota and is recommended as an exclusive nutrient source for the first six
months (Kramer and Kakuma 2004; Cattaneo et al. 2005; Section on Breastfeeding 2012).
Introduction of breast milk provides the  infant with different types of growth factors,
antimicrobial peptides and growth hormones along with microorganisms and their preferred
growth substrates that help in maturation of the intestinal microbiota and immune system
including the gut barrier and defence systems (Oftedal 2002; Petherick 2010; Walker 2010;
Bezirtzoglou, Tsiotsias, and Welling 2011; Ballard and Morrow 2013). Alteration in natural
colonization of the gut microbiota during infancy has been associated with an increased risk
for inflammation, autoimmune diseases, allergies, diabetes, Inflammatory Bowel Disease
(IBDs), obesity and atopic dermatitis (Mackie, Sghir, and Gaskins 1999; Akobeng et al. 2006;
Ogra and Welliver RC 2008; Guaraldi and Salvatori 2012).
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Inclusion of probiotics as supplement and in staple foods have become popular as they  can
trigger notable health benefits especially in diarrhoeal diseases and potentially in preventing
allergy (Metchnikoff and MITCHELL 1907; Hotel and Cordoba 2001; Pflughoeft and
Versalovic 2012). Extensive use of probiotics can alter the amount of microbial commensals
in gut, suppress pathogens, stimulate the proliferation of epithelial cells and fortify intestinal
barriers in both infants and adults (Othman, Neilson, and Alfirevic 2007; Thomas and
Versalovic 2010; Bron, Van Baarlen, and Kleerebezem 2012; Hemarajata and Versalovic 2013;
Govender et al. 2014). Lactobacillus rhamnosus GG, originally isolated from human
gastrointestinal tract, is one of the most studied probiotic bacteria which has many health
benefits (Alander et al. 1999; Gorbach 2000; Näse et al. 2001; Doron, Snydman, and Gorbach
2005; Parvez et al. 2006). Various studies have revealed L. rhamnosus GG’s effectiveness
against respiratory tract infection and different types of diarrheas in children (Guandalini et al.
2000; Hatakka et al. 2001). Meticulous study of L. rhamnosus GG’s proteinaceous host-
interacting pili and pilin subunit SpaC have identified  it to be the key component for interacting
with host tissues and conferring the prolonged persistence of L. rhamnosus GG in human
gastrointestinal tract which lacks in other strains of Lactobacilli (Kankainen et al. 2009; von
Ossowski et al. 2010; Reunanen et al. 2012; Douillard et al. 2014; Rasinkangas et al. 2014).
Use of antibiotics is also one key factor that can influence the development of the microbiota.
Use of antibiotics can have profound effects upon adult’s microbiota but especially during the
vulnerable microbial colonization and maturation process in children (Van der Waaij 1983;
Ledger and Blaser 2013; de Tejada 2014; Stokholm et al. 2014; Korpela et al. 2016; Langdon,
Crook, and Dantas 2016). This disturbance in colonization process has been directly associated
with infant’s risk for obesity, diabetes, IBDs, atopic dermatitis and asthma during their
childhood and later in life (Kozyrskyj, Ernst, and Becker 2007; Algert et al. 2009; Decker et
al. 2010; Hviid, Svanstrom, and Frisch 2011; Huh et al. 2012; Trasande et al. 2013; Mueller et
al. 2015b).
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3. Aims and Objectives
Aim of this experimental study was to develop and validate a high throughput method for
processing and extracting bacterial DNA for microbiota analysis from human fecal samples.
The study consisted of two parts with the following objectives:
To develop, optimize and validate high throughput fecal sample processing system for
gut microbiota analysis
· To develop a fecal sample collection method and storage system optimal for high
throughput studies
· To optimise and validate an efficient, semi-automated and high throughput DNA
extraction method for fecal samples, focusing on the optimization of cell lysis parameters
and semi- automated DNA purification system to achieve cost-effective and high-quality
DNA extraction
To apply the newly optimized and validated high throughput fecal sample processing
system for extraction of DNA from fecal samples collected in a clinical trial and use the
samples to study the prevalence of probiotic bacterium, L. rhamnosus GG in infant and
maternal fecal samples using PCR methods
· To study the prevalence of probiotic L. rhamnosus GG in 3 months old infants from two
cohorts sampled ~10 years apart
· To compare the transfer of L. rhamnosus GG within infant-mother dyads longitudinally
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4. MATERIALS AND METHODS
4.1. Study design
This study was designed as master’s thesis project to develop, validate and apply a semi-automated
high throughput fecal sample processing system to extract microbial DNA. A subset of the samples
was used to study the prevalence and carriage of Lactobacillus rhamnosus GG using species specific
PCR amplification method. A detailed study design and workflow is displayed in Figure 3 below.
Figure 3 A brief explanation of this study designed as a Master's Thesis project
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4.2. Trials and samples
Various in house and drop out fecal samples from infants and adults were used during the
optimization and scale up of the fecal sample processing system. Selected samples had been
previously processed and analyzed for the microbiota composition. Details of the samples are
shown in Table 1.
Table 1 Fecal samples used for optimization and validation during the development of high
throughput fecal sample processing and DNA extraction system
Sample ID Group Age (months)
Ab36
Child
5
Ab41 1
Ab63 2
Ab91 2
UH1
Adult
UH2
UH3
INT1
Fecal samples collected in a clinical trial involving mother and infants were processed using
the developed method. Randomly picked subsets of these and previously extracted infant
samples were used to study the prevalence and carriage of L. rhamnosus GG. These clinical
trials are described below.
4.2.1. JORVI study
JORVI is an ongoing study led by Dr. Kaija-Leena Kolho from Helsinki University Hospital.
It is a randomized controlled study where 60 mothers were recruited from the labour ward at
Jorvi hospital, Espoo in 2015-2016. Half of the mothers (30) received prophylactic antibiotics
during the labour and the rest (30) were not administered any antibiotics. Fecal samples from
the mothers and infants were collected at seven different time points: At birth, 1 week (w), 2
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weeks, 1 month (m), 3 months, 6 months and 12 months. The infant feces were collected from
the diapers. In case of fully absorbed (liquid) feces, the sample was collected by tapping the
diaper with cotton swab instead of a tube with scoop. Rectal swabs were taken from the mother
at the day of childbirth if natural fecal sample could not be produced. Only samples collected
by April 2016 were available for this study and hence were used for DNA extraction. By that
time, 28 mother-infant pairs have donated the first 5 samples from birth until 3 months (Figure
3) which were used in this project to study the prevalence of L. rhamnosus GG among infants
at 3 months and its co-occurrence between mothers-infant dyads at different time points using
L. rhamnosus GG (Sortase C gene) specific end-point PCR. Figure 3 and Table 2 explain the
JORVI study design and available data in brief.
Figure 4 JORVI study design, first five samples (shaded) from birth until 3 months (3m) were
used to study the prevalence of L. rhamnosus GG in the samples.
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Table 2 Available information of 28 mother-infant pairs selected to study LGG's prevalence
and its temporal dynamics. Fecal samples collected until 3 months and their relevant
information were only used and analyzed for prevalence and study of transfer of LGG from
pregnant mothers to their child.
Groupsè
Headingsê
Mothers Children
Antibiotics intervention
until birth
Birth-3 months
Antibiotic Non Antibiotic Antibiotic Non Antibiotic
Total 28 14 14 14 14
Average age (y.) 33.5
Male 10 6
Female 4 8
Vaginal delivery 23
Caesarean delivery 5
Breast feeding 4 7
Formula milk 1
Breast and formula milk 9 7
Under medication 6 4 3
Additional antibiotics 2 4 1 2
Probiotic Supplement (PS) 6 7 5 13 12
PS containing LGG 5 5 2 10 6
Vitamin D supplement 11 11
Probiotic Foods (PF) 11 8 9
PF containing LGG 5 4 1
Drinking or using milk products 25 14 14
4.2.2. FLORA study
FLORA is a probiotic intervention study conducted from 2003 to 2005 by Dr. Erkki Savilahti
and Dr. Mikael Kuitunen from Helsinki University Hospital. Pregnant mothers whose infants
had an increased risk for allergy were recruited at antenatal clinics through advertisements in
Helsinki. Full description of the study and results regarding the effect of intervention on the
incidence of allergic diseases at two years have been published in 2007(Kukkonen et al. 2007).
In brief, pregnant mothers (N=1223) at 35 gestational weeks were randomized to either
probiotic or placebo group. Mothers in the probiotic group received a capsule twice daily for 2
to 3 weeks before delivery containing a mixture of Lactobacillus rhamnosus GG, Lactobacillus
rhamnosus LC705, Bifidobacterium breve Bb99 and Propionibacterium freudenreichii ssp.
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shermanii JS (DSM 7076). Capsules contained microcrystalline cellulose in the placebo group.
For 6 months after the birth, the infants in the probiotic group received an opened probiotic
capsule with 20 drops of sugar syrup containing 0.8g of galacto-oligosaccharides daily. While
the infants in the placebo group received sugar syrup without galacto-oligosaccharides. Fecal
samples from infants were collected at 3 months and 6 months.
For this project, pre-extracted microbial DNA from 3-month samples from 30 children (born
~2003) were randomly selected from control group (placebo) to study the prevalence of L.
rhamnosus GG in infant’s gut against similarly analyzed fecal samples from 3 month’s old
children (born ~2015/16) from JORVI study. The following diagram explains FLORA study
in detail (Figure 5).
Figure 5 A detailed diagram showing FLORA study conducted between 2003 and 2005 in
which half of the pregnant mothers and their child were administered probiotics 4 weeks before
giving birth and after birth until 6 months, respectively. Gut microbiota is studied using fecal
samples collected from the infants at age of 3 and 6 months. In this study, fecal samples from
children in the placebo group at 3 months was used to study the prevalence of L. rhamnosus
GG among 3 month’s old infants.
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4.3. Fecal DNA extraction and optimization of parameters
Setting up a new high throughput fecal sample processing system in 96 well format involves
multiple steps and components. In this study, we tested, optimized and validated the following
components and procedures as part of the workflow required to obtain PCR-compatible DNA
from fecal sample (Figure 6).
Figure 6 A simple workflow for obtaining purified DNA from fecal sample.
New fecal sample collection system for infants (sample), transit from self-made bead beating
tubes to commercial ones and selection of beat beating conditions (lysis), transition from
column-based (manual) DNA purification to automated process using KingFisher™ Flex
(binding) and wash buffers for DNA purification (washing). In addition, minor experiments,
not described in this thesis, were performed to upscale the bead beating from 24-format to 96-
format, to accommodate 96 well plates to VorTemp™ 56 (Labnet International, USA) and to
accurately quantify DNA in 96 well format.  In the optimization phase bead beatings were
performed in FastPrep®-24. A new protocol for extraction of microbial DNA from adult and
infant fecal samples was established at the end.
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4.3.1. Development of new fecal sample collection system for infants
Before optimizing DNA extraction and purification system, a new fecal sample collection
technique was developed especially for infants according to the need in the forthcoming large
HELMi-study focusing on early life microbiota. Four collection techniques were tested (Table
3) using real infant feces samples of different texture to obtain roughly ~250 mg sample, i.e.
the required amount of fecal material for the manual repeated bead beating (RBB) method. Lab
colleagues and two mothers were asked for their comments after testing different techniques.
The newly developed infant’s fecal sample collection procedure can be found in appendix A
and properties of each technique is enlisted in Table 3.
Table 3. Different collection tools tested for the development of new sample collection system
for infant feces.
S.N. Collection tool Suitability for fecal types
1 Cotton swab Liquid
Solid
Semi solid
Liquid
Solid or semisolid
2 Stick with propeller
3 Dropper
4 Coffee stirrer stick
4.3.2. Bead beating tubes and sample preparation
Two types of bead beating tubes, self-made and readymade commercial tubes, were used
during the establishment and validation of high-throughput system for processing fecal samples
(Table 4). Self-made tubes were successfully used in the laboratory, but they were not suitable
for large scale study because of the time needed for their preparation. Self-made bead beating
tubes were prepared by weighing autoclaved 0.25 g of Ø 0.1 mm zirconia/silica beads
(BioSpec, Catalog # 11079101z) and 3 Ø 2.5 mm glass beads (BioSpec, Catalog # 11079125)
into 2.0 ml screw cap tubes (Sarstedt 72693). Commercial bead beating tubes (pre-filled with
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beads) were provided along with MagMAX™ Total Nucleic Acid Isolation Kit, ThermoFisher
Scientific (AM1840).
In case of preparation of fecal sample for microbial DNA extraction, for self-made tubes ca.
0.125 g of fecal matter is weighed into the tube (with beads) and 0.5 ml lysis buffer (500 mM
Sodium Chloride, 50 mM Tris- Hydrochloric acid pH 8, 50 mM Ethylenediaminetetraacetic
acid and 4% Sodium dodecyl sulfate) is added and bead beating is performed. In case of
commercial tubes, ~0.25 g feces is weighed into 2 ml Eppendorf tube, homogenized by
vortexing with 1X phosphate buffered saline (PBS) pH 7.4 (0.5 ml for infants or 1.0 ml for
adult feces samples), then centrifuged at 100 x g for 1 min and 175 µl supernatant is transferred
into commercial bead beating tubes with pre-dispensed 235 µl lysis buffer and bead beating is
performed.
Table 4 Characteristics of the two types of bead beating tubes tested.
Bead Beating tubes Properties
Self-made
- Tubes need to be sterilized
- Zirconia and glass beads are weighed and filled manually
- Capacity: ~1500 µl
- Preparation is exhausting and time consuming
Readymade
or
Commercial
- Sterile tubes with pre-filled beads
- Capacity: ~400 µl
- Ready to use
- Price >10x higher than for self-made
4.3.3. Mechanical cell lysis by bead beating
Mechanical cell lysis can be achieved by two types of bead beating methods, normal bead
beating (BB) and repeated bead beating (RBB). Both methods were tested for lysing both adults
and infant’s fecal samples.
Normal bead beating (BB) is performed at speed of 6.5 m/s (FastPrep®-24, MP Biomedicals),
two cycles of 1 min each with 5 min rest between the cycles. Beads and solid particles are
pelleted by centrifuging at 16000 x g for 3 min and ~300 µl of lysate is transferred into an
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empty Eppendorf tube (for high-throughput system lysates are collected in a 96-deep well
plate). Lysates (in tubes or deep well plate) were stored in ice if purification is not done
immediately.
Repeated bead beating (RBB) is performed at speed of 5.5 m/s (FastPrep®-24, MP
Biomedicals), three cycles of 1 min each with 5 min rest in between the cycles. The lysate is
incubated at 95°C for 15 min (VorTemp™ 56, Labnet) with gentle shaking. Beads and solid
particles are then pelleted by centrifuging at full speed for 5 min in room temperature and the
lysate is transferred into a new 2 ml Eppendorf tube (in 96 deep well plate for high-throughput
processing) and stored in ice to minimize the physical damage of DNA. For physical disruption
of the remaining intact cells, fresh lysis buffer is added to the tubes again and the whole bead
beating step is repeated. Second lysates are transferred into the same tubes or same 96 well
deep well plates containing first lysate and mixed properly. Lysates (first and second pooled)
were stored in ice if purification was not performed immediately. The amount and form of the
sample and volumes of lysis buffer for different type of tubes are shown in Table 5.
Table 5. Amount and form of fecal matter and volume of lysis buffer pipetted into the bead
beating tubes for repeated bead beating method (RBB).
Tube type Amount and form of fecal matter Lysis buffer (µl)
1st round 2nd round
Self-made 1st round: ~0,125 g crude feces + lysis buffer
2nd round: Leftover fecal material + lysis buffer
500 150
Commercial 1st round: 175 µl supernatant + lysis buffer
2nd round: Leftover fecal material + lysis buffer
235 100
4.3.4. Purification of DNA
Lysates obtained after the bead beating step contain released nucleic acids but also all the other
components of fecal matter. Purification of nucleic acids was performed with manual method
only during the optimization and validation of different methods. Most of the DNA lysates
were purified using automatic purification system.
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Manual purification method
Precipitation of the extracted nucleic acids (NA) was done as explained in (Salonen et al. 2010).
The precipitates were further purified using QIAamp® DNA Mini Kit (250) (Cat. No. 51306)
and by following the protocol recommended by the manufacturer.
Automatic purification method
Two different purification systems were used for the optimization and implementation phase.
During optimization, KingFisher™ Duo Prime Purification System (Thermo Scientific™) was
used which can process 12 samples in one run. After this sytem was scaled up to 96 well format
high throughput purification system, Thermo Scientific™ KingFisher™ Flex, which can
process 96 cell lysates at once. For both systems, we used MagMAX™ Total nucleic Acid
Isolation Kit, AM1840 (Ambion life technologies) according to the recommendation and
earlier results by the instrument manufacturer (Thermo Scientific™).
§ KingFisher™ Duo Prime Purification System
Samples and reagents were prepared and pipetted in a standard KingFisher™ Deep-well 96
plate following the instructions provided with the DNA extraction kit. Modified
MagMAX_Pathogen_High_Vol_Duo protocol was selected for the purification. Purified DNA
obtained in elution strip were transferred into new Eppendorf tubes or strips and were stored at
+4°C temporarily until concentrations were measured and as required for further experiments,
before storing in -20 °C.
§ Thermo Scientific™ KingFisher™ Flex purification system
This high throughput system was used to purify up to 96 samples in one run using the standard
instructions provided by the manufacturer and available in the kit (Ambion life technologies,
MagMAX™ Total nucleic Acid Isolation Kit, AM1840, USA). Thermo Scientific™
Multidrop™ Combi Reagent Dispenser was used to dispense reagents into several 96 well
plates required during the run. A detailed protocol for extraction of microbial DNA using this
system can be found in appendix B. Modified MagMAX_Pathogen_High_Vol_Duo protocol
was used for the preparation of samples and reagents for the purification. Purified DNA
samples were eluted in 96 well plate which could be directly stored at +4 °C or -20 °C as
specified above.
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4.3.5. Preparation and performance validation of wash buffers
Wash buffers for the purification of nucleic acids were self-prepared and tested for their
compatibility with the kit and performance. This was motivated by the fact that the volumes of
wash buffers required for the automated DNA purification by using KingFisher™ Flex and
MagMAX_Pathogen_High_Vol_Duo protocol exceeded those provided in the kit
(MagMAX™ Total nucleic Acid Isolation Kit, AM 1840, Lithuania), and we wanted to test
whether instead of purchasing expensive extra wash buffers we could use self-made ones.
Information on the composition of the commercial wash buffers were not available and hence
Literature search was performed  to determine the optimum composition of wash buffers for
purification of genomic/bacterial  DNA (Durst and Staples 1972; Dellaporta, Wood, and Hicks
1983; Piškur and Rupprecht 1995; Yagi et al. 1996a; Somma and Querci 2004; Tan and Yiap
2009; Zumbo 2012; OpenWetWare contributors 2016). Composition of wash buffers prepared
in the lab was selected based of the non-hazardous and easy handling property along with
excellent performance when compared with commercial buffers. The composition of selected
self-made wash buffers (HWI, HWI_E and HWII) are shown in Table 6. Final pH of the wash
buffers was maintained near to 8, like that of commercial wash buffers present in MagMAX™
Total nucleic Acid Isolation Kit. For wash buffer 1 with EDTA (HWI_E) pH of the solution
(Sodium Acetate and EDTA) was maintained near 8 before autoclaving and ethanol was added
afterwards.
Table 6.Composition of self-made wash buffers prepared in laboratory for automated
purification of DNA from cell lysates obtained from fecal samples.
Wash Buffer I Final Concentration
HWI Sodium Acetate (pH 5.2) 0.3 M
Ethanol 70%
HWI_E Sodium Acetate (pH 5.2) 0.3 M
EDTA (pH ~8.0) 10mM
Ethanol 70%
Wash Buffer II
HWII Tris-HCl (pH 8.0) 10mM
Ethanol 70%
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Microbial DNA from fecal samples were purified using both commercial (wash I and Wash II)
and two sets of self-made wash buffers (HWI/HWII and HWI_E/HWII). DNA yields obtained
after purification were compared against each other. A qPCR specific to Bacteroides bacteria
group was performed to test the PCR-compatibility of the DNA extracts obtained with the self-
made wash buffers versus the commercial wash buffers by comparing the changes in Threshold
Cycle (Cq) along with the variation in template amount, as potential sign of PCR inhibition.
4.3.6. Quantification and quality control of extracted DNA
In case of few samples, NanoDrop™ (ND1000 Spectrophotometer, Thermo Scientific™) and
Qubit® Fluorometer (Invitrogen™, CA 92008, USA) were used to measure concentrations of
microbial DNA obtained from processed fecal samples. Standard instruction provided by
manufacturer for Nanodrop™ and Qubit® dsDNA HS Assay kit were used for measurement
of the DNA concentration. PicoGreen® dsDNA quantitation assay was used to measure the
DNA concentrations in 96 well layout (leaving 86 samples for measurements in single assay
except the standards used to construct standard curve). FLUOstar OPTIMA Microplate Reader
(BMG Labtech, Germany) was used to measure the DNA concentrations along with standard
instruction provided with Quant-iT™ PicoGreen™ dsDNA Assay Kit Ref. P7589
(ThermoFisher™, USA).
For quality control and visual inspection of the DNA agarose gel electrophoresis was
performed. 1 to 3% agarose gels were stained with Midori Green Advanced DNA stain
(NIPPON Genetics EUROPE GmbH, Cat no. MG 04), extracted DNA were loaded in the gels
to visualize different sizes of DNA e.g. after bead beating experiment and the results were
visualized under the UV transilluminator (Gel Doc™ XR+, Molecular imager®, BIO-RAD,
USA). Similar procedure was also used to verify the products obtained from PCR.
4.3.7. Establishment of high throughput fecal sample processing system
After all testing and optimizations of tubes, instruments, buffers, purification and quantification
methods, an efficient system capable of extracting automatically purified microbial DNA from
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96 adults or infant’s fecal samples was set up in the laboratory. A detailed protocol for
extracting microbial DNA from fecal samples in high throughput fashion using readymade
bead beating tubes, FastPrep®-96 and Thermo Scientific™ KingFisher™ Flex purification
system is included in appendix B.
4.4. Analysis of fecal bacteria
Extracted fecal DNA samples were subjected to several bacterial genus, species or strain
specific PCRs (end-point and real time), and sequencing of 16S rRNA gene amplicons using
MiSeq platform to determine the overall microbiota composition.
4.4.1. Full length 16S rRNA PCR
The DNA concentrations obtained from adult samples were in satisfactory level unlike those
from swab samples (Esp. for JORVI study samples) which were mostly ≤1 ng/µl and some
even in negatives. To ratify the presence of microbial DNA in those low- concentration samples
extracted using the RBB method (as described in section 4.3) and purified using self-made
wash buffers, PCR reaction was performed to amplify full length of 16S rRNA gene (~1500
bp) using F:5’-GAGAGTTTGATYCTGGCTCAG-3’ and R:5’-
AAGGAGGTGATCCARCCGCA -3’ primers (Wang et al. 2009) obtained from Oligomer Oy,
Finland. The 25 μl PCR reaction mixture contained 0.4 μM of forward and reverse primers, 0.2
mM dNTPs (ThermoScientific™), 1.25 U of DNA polymerase (Thermo Scientific™
DreamTaq DNA Polymerase #EP0702), 2.5 μl DreamTaq buffer of same company, 18.75 μl
Milli Q water and 1 μl of DNA template. The PCR program contained 2 min. of initial
denaturation at 95°C followed by 25 cycles of 20 sec. denaturation at 95°C, 20 sec. annealing
at 55°C, 1 min. of elongation at 72°C and finally 5 min. of final elongation at 72°C. The PCR
result was visualized using 1% agarose gel.
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4.4.2. Real-Time PCR (qPCR) for abundant bacteria
Real-time PCR or qPCR was performed to target the 16S rRNA gene to quantify the dominant
bacterial groups among the intestinal microbiota from DNA extracted from fecal samples.
Firstly, Bacteroides qPCR was performed when testing the self-made wash buffers. Secondly,
total bacteria and abundant bacterial groups (Bacteroides, Clostridium and Bifidobacterium)
were quantified from the DNA preps extracted using the high throughput method with self-
made wash buffers for several (adult and infant) test samples to evaluate the presence of
amplifiable DNA with minimal presence of PCR inhibitors. In the last part of the thesis
experiments, a new L. rhamnosus GG specific qPCR was developed and validated to replace
the old unspecific end-point PCR method. Both PCR methods were used to identify and
quantify L. rhamnosus GG from the same 3 month’s old children samples from FLORA (n=30,
control group) and JORVI (n=28, antibiotic and non-antibiotic group) studies and the results
were compared. The details of these PCR assays including the bacterial target, primers,
template amount, bacterial standards, annealing temperatures and detection temperatures are
specified in Table 7.
The qPCR amplification and detection were performed using C1000 Touch® Thermal Cycler
(BIO-RAD) with HOT FIREPol® EvaGreen® qPCR Mix Plus (Solis BioDyne, Estonia). All
reactions were performed in triplicates and outliers were removed (criteria) prior to further
analysis. The qPCR conditions have been described in detail elsewhere (Rinttilä et al. 2004;
Salonen et al. 2010). In brief, 25 µl reaction contained 0.20 µM of both primers (Oligomer Oy,
Finland), 5 µl of qPCR mix, 14.8 µl of MilliQ water and 5 µl of DNA template. The PCR
program included a 1 min initial denaturation at 95°C, followed by 39 cycles of 15 sec
denaturation at 95°C, 20 sec annealing (50°C to 68°C) and 30 sec elongation at 72°C, detection
from 72°C to 90°C (varies with target bacteria group or specific strain) for 10 to 30 sec. After
39 cycles 1 min of denaturation at 95°C finishing with plate read from 55°C to 95°C with 0.5°C
increment in every 0.05 sec for melting curve. Results from qPCR were analyzed by
constructing log10 standard curves using known amounts of bacteria present in standards, to
convert the threshold cycle (Cq) values into bacterial DNA copy numbers/g of wet feces in as
described previously (Salonen et al. 2010).
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Table 7. Information about the target bacterial group or specific strain, primers, standards, template amount, annealing temperature, detection
temperature and references for qPCR assays used in this thesis.
Target Primers Bacterial
standard
Template
amount
(ng)
Annealing
temperature
(°C)
Detection
temperature
(°C)
Reference
Total bacteria F: 5'-TCCTACGGGAGGCAGCAGT-3'
R: 5'-GGACTACCAGGGTATCTAATCCTGTT-3' Bifidobacterium
longum
0.5 50 82
(Nadkarni et al. 2002)
Bifidobacterium
spp.
F: 5'-TCGCGTC(C/T)GGTGTGAAAG-3'
R: 5'-CCACATCCAGC(A/G)TCCAC-3'
25 58 85
(Rinttilä et al. 2004)
Bacteroides spp. F: 5'-GGTGTCGGCTTAAGTGCCAT-3'
R: 5'-CGGA(C/T)GTAAGGGCCGTGC-3'
Bifidobacterium
fragilis
0.5 68 80
Clostridium
coccoides spp.
F: 5'-CGGTACCTGACTAAGAAGC-3'
R: 5'-AGTTT(C/T)ATTCTTGCGAACG-3'
Ruminococcus
productus
0.5 55 85
Lactobacillus
rhamnosus GG
F: 5'-CATTCATGTTGCATCGTCCT-3'
R: 5'-GCTTGGCCGGACTAAGTACA-3'
L. rhamnosus
GG spiked with
fecal DNA
12.5 60 72 and 81 Method developed by
Pia Rasinkangas and
protocol is unpublished
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4.4.3. Lactobacillus rhamnosus GG specific PCR
End-point PCR assay targeting the Sortase C (srtC) gene (Figure 7) for screening of L.
rhamnosus GG genome was used to identify and confirm the presence of L. rhamnosus GG in
fecal samples. It was used to study the prevalence of L. rhamnosus GG among 3 month’s old
children from FLORA (control group) and JORVI study, and co-occurrence of L. rhamnosus
GG between mother-infant dyads from JORVI study. Sortase C (srtC) gene was amplified
using specific forward (5'-AGTGCGACTATTAGCTTTA-3') and reverse (5'-
GGATCTTGTGACCTTAATG-3') primers (Table 7) (Oligomer Oy, Finland) and the PCR
product (150 bp) was confirmed by visualizing in agarose gel and by sequencing the product
using Sanger sequencing. The 25 µl of reaction mixture contained 12.5 µl of master mix
(Thermo Scientific™ Phusion High-Fidelity PCR Master Mix, F531), 1.25 µl primers (10 µM),
5 µl water and 5 µl DNA template (1:10 diluted fecal microbial DNA). PCR reaction program
included 3 min of initial denaturation at 98°C followed by 30 cycles of 20 sec of denaturation
at 98 °C, 30 sec of annealing at 60°C and 1 min of elongation at 72°C, and finally a 5 min of
elongation at 72°C.
Figure 7. Schematic presentation of the end-point PCR target site (srtC gene) of L. rhamnosus
GG, resulting in PCR product of 150 bp.
4.4.3.1. Lactobacillus rhamnosus GG specific qPCR
This method was developed by Pia Rasinkangas, PhD (previously a post-doc researcher in
Willem De Vos group, Haartman institute, University of Helsinki and currently Scientist at
DuPont, Finland). For improved specificity, a new site was targeted for amplification that
contained partial srtC gene and in addition flancking L. rhamnosus GG’s sequence (srtC
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border) resulting in 238 bp product (Figure 8). This method was tested and optimized by myself
outside of my thesis project so the details regarding the optimization and validation of this
method are not discussed here (manuscript in preparation).
In this project, this newly developed and optimized qPCR assays was used for specific
detection and quantification of L. rhamnosus GG from fecal DNA extracted from infants at 3
months from FLORA (control group) and JORVI (microbial DNA extracted using the newly
developed high throughput system) trials, and the results were compared against the srtC end-
point PCR method.
Figure 8. L. rhamnosus GG specific real-time PCR target site of L. rhamnosus GG resulting
in PCR product of 238 bp.
For this assay, the entire qPCR protocol was redesigned to ensure specificity of the assay to
identify and quantify L. rhamnosus GG. Each standard was spiked with 25 ng of fecal DNA
(devoid of L. rhamnosus GG) to make their amplification conditions analogous to that of the
fecal DNA and the template amount for reaction was limited to 12.5 ng. The PCR reaction had
denaturation temperature 98°C, 29 cycles and final plate reading from 65°C to 95°C with 0.5°C
increment in every 0.05 sec. for melting curve. Results were similarly analyzed as explained
under Real Time PCR (qPCR) previously. Detail about primers, template amount, bacterial
standard, annealing temperature and detection temperatures are specified in Table 6.
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4.4.4. Sequencing
To study the microbiota composition of the selected fecal DNA extracts from infant samples
and confirm their suitability for the established library preparation protocol, the samples were
analysed using Next generation sequencing. The PCR products from both PCR methods
targeting L. rhamnosus GG srtC derived from selected fecal samples were sequenced using
Sanger sequencing method. Basically, NGS allows us to process large amount of sample at one
run and can sequence millions of fragments while sanger sequencing can only handle few
samples and produce one forward and reverse reads with 99% accuracy (Gurson 2015).
Although NGS have been in use extensively but during planning phase and for confirmation
of products before heading towards large scale sanger sequencing is considered as feasible and
reliable method. The samples were sequenced at Institute for Molecular Medicine Finland
(FIMM), Finland.
Next generation sequencing (Illumina MiSeq)
During optimization phase of high throughput fecal sample processing, microbial DNA
extracted from infant’s fecal samples using different types of bead beating tubes and methods
were sequenced using next generation sequencing method. The samples were prepared by
amplifying V3 & V4 regions of the 16S rRNA gene using the locus specific primers 341F and
785Rev (Klindworth et al. 2013) with TruSeq overhangs (F: 5’-
CTCGTCGGCAGCGTCAGATGTGTATAAGAGACAG-3’ and R: 5’-
GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAG-3’) and barcoding primers
according to the protocol kindly provided by Institute for Molecular Medicine Finland (FIMM),
Finland that follows the 16S Metagenomic Sequencing Library Preparation (15044223 B)
protocol by Illumina® (Amplicon, Clean-Up, and Index 2013) with small modifications. The
PCR reaction was performed in 20 µl reaction containing 1 µl primers (0.25µM), 10 µl of
master mix (Thermo Scientific™ Phusion High-Fidelity PCR Master Mix, F531), 7µl of MilliQ
water and 1 µl of DNA template. Different concentrations and volumes of template DNA were
tested and according to the previous unpublished results from de Vos laboratory, 1 µl of
template DNA at concentration 1 ng/µl was considered optimum as it provided the highest
percentage of PCR-positive samples copared to higher input of fecal DNA. PCR program
included an initial denaturation at 98 °C for 30 sec. followed by 25 cycles of denaturation at
98 °C for 30 sec., annealing at 62 °C for 30 sec., extension at 72 °C for 15 sec. and program
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ended with final extension at 72 °C for 10 min. The PCR products were visualized in agarose
gel as preliminary screening, LabChip® GX Touch system (PerkinElmer®, USA) was
introduced for high throughput quantification, quality assessment and capillary electrophoresis
separation of purified and amplified DNAs.
The pooled libraries were sequenced with Illumina® MiSeq® platform. Data preprocessing
and taxonomic annotation of the reads was performed in R package mare
(https://github.com/katrikorpela/mare) by Anne Salonen (my thesis supervisor) before I
analyzed them in Excel.
Sanger sequencing
PCR products obtained from old (end-point) and new (real-time) L. rhamnosus GG specific
PCR methods were sequenced to evaluate the specificity of each method to correctly target L.
rhamnosus GG from microbial DNA extracted from fecal samples. PCR products from both
PCR methods were first purified using GeneJET™ PCR purification kit, Thermo Scientific™,
Lot. 00134915 following the protocol provided by manufacturer. Samples for sequencing were
prepared by mixing 5 µl of purified DNA (40 ng) with 1.6 ul of 5uM forward primer (used in
PCR reaction). NCBI BLAST tool was used to identify the origin of sequences in the PCR
products.
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5. RESULTS
Results from various experiments are arranged in two sections, section 1 for the optimization
and validation of high-throughput system for processing fecal samples and section 2 for
studying the prevalence and transfer of L. rhamnosus GG in a subset of the extracted samples.
5.1. Section 1: Development and standardization of fecal sample collection system
A high-throughput system is effective only when there is a feasible, efficient and reproducible
fecal sample collection technique. Our aim was to develop a new sampling strategy for infant
feces to replace the commercial options for fecal home sampling that usually employ ≥15 ml
tubes despite of a relatively small sample size, taking a lot of freezer space. Weighing the
required amount of sample for DNA extraction takes half of the total processing time and hence
eliminating this step from the DNA extraction protocol was our priority. Infant’s fecal samples
are normally semi solid or watery so they are tricky to collect, and an optimum method for
collecting fecal samples of different consistencies was thus required. We tested four collection
techniques using real feces of different nature and consistency. The collective results and
comments are presented in Table 8.
Table 8. Outcome of the test for four different collection techniques for infant feces.
Collection
technique
Fecal type Sample
collected (g)
Remarks
Cotton
swab
Solid 0.030 Suitable for collection of watery samples but not possible to collect
solid (dry) fecesSemi solid 0.300
Stick with
propeller
Solid 0.290 Short length of the stick makes it difficult to collect samples
properly, useful to collect solid samples onlySemi solid 0.493
Plastic
dropper
Solid 0.261 Difficult to collect dry samples and unsafe (to cut the tip). Fluffy
and watery samples are easier to collect due to suction bulb on topSemi solid 0.243
Coffee
stirrer stick
Solid 0.327 Easy to collect all kinds of samples esp. for solid and semi solid
samples. For liquid samples, the tube must be placed very close to
the collection stick
Semi solid 0.393
Liquid 0.304
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Tests revealed the coffee stirrer stick as the best method for collecting fecal samples and a
protocol was made in which study subjects were instructed to collect a pea sized dollop (~250
mg) of baby feces into 2 ml cryo tubes with outer screw grips (less messy than tubes with
inward grip), place them in the cool transport container (Sarstedt) and store in -200C until taken
to study center or collected by responsible person (Protocol in Appendix A). By now this
protocol has been successfully implemented in large HELMi (https://helmitutkimus.com/) birth
cohort study to collect thousands of samples, and the time required for microbial DNA
extraction from 96 fecal samples have shorten by 3 hours compared to the old procedure
including sample aliquoting as the first step.
5.2. Microbial DNA extraction methods, bead beating tubes and DNA yields
Before scaling up and optimization of DNA extraction in 96-well format, 4 infants and 4 adult’s
fecal sample were used for initial screening of different extraction methods using two types of
bead beating tubes along with two different DNA purification methods. The following methods
and components were tested:
DNA extraction methods
a) Repeated Bead Beating (RBB)
b) Bead Beating (BB)
Bead beating tubes
a) Self-made bead beating tubes (ST)
b) Commercial (ready-made) bead beating tubes (RT)
DNA purification systems
a) QIAamp® DNA Mini Kit (250) – Manual purification
b) KingFisher™ Duo Prime purification system – Automatic purification
The manual DNA extraction method that had been previously validated in our laboratory for
adult fecal samples (Salonen et al. 2010) was used a basis for upscaling the DNA extraction
method; employing the option a) in the above listing. Before this project, the initial validation
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of for the use of KingFisher™ Flex purification system for semi-automated 96-format fecal
DNA extraction had been performed, indicating that for adult samples the DNA yields were
comparable between the manual and automated DNA purification method (data not shown).
However, as the bead beating procedure from the manual system is not feasible for 96-format,
we needed to adjust and optimize the method for the upscaled protocol. Hence, we compared
the performance of self-made bead beating tubes, adapted from the manual protocol to the
commercial bead beating tubes that come as part of the DNA extraction kit (MagMax™ Total
nucleic acid Isolation Kit, AM1840) that had been selected for automated DNA purification
based on the recommendation of the KingFisher™ technical support. As the two types of bead
beating tubes arguably differ on their sharing efficiency due to differences in tube volume and
shape (Table 4 and 5), we also tested if longer (repeated beat beating, RBB) or shorter (simple
beat beating, BB) treatment yields better results with the commercial bead beating tubes that
are needed for the 96-format. Manual extraction was used as a reference for the automated
purification with the KingFisher™ Duo Prime purification system, a 12-sample set-up version
of the KingFisher™ Flex Purification System operating in 96-format. Four infant (aged 1 to 5
months) and four adult fecal samples were used for these tests. Due to the small sample size
the results are descriptive and no statistical testing was performed.
Figure 9. DNA yields in absolute amount (I) and normalized per sample weight (II) from
different samples and treatments. Adult and baby fecal samples were processed using Repeated
Bead Beating (RBB) and Bead Beating (BB) methods in readymade (RT) and self-made bead
beating tubes (ST) using manual and automatic DNA purification systems.
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Based on the fluorometric measurements, the largest difference in the DNA yields derived from
the tubes; the self-made bead beating tubes gave ca. 2.7-fold higher absolute DNA yield (7.57
µg) when normalized to the sample weight compared to the readymade tubes in case of child’s
fecal samples (Figure 9). This is logical given that the volume of readymade tubes is 2.5x
smaller (Table 5). In the readymade tubes that are needed for high throughput system, the
average DNA yields were comparable between the BB and RBB methods for adult samples
both in absolute (2.58 and 2.62 µg) and normalized (14.58 and 16.17 µg/mg feces) terms. Also
in case of the infant samples, the yields between the BB method (2.88 µg) and RBB method
(2.57 µg) were quite similar, but the normalized DNA yields were lower with the BB method
(42.55 vs 59.70 µg/mg). An agarose gel was additionally used to determine the effectiveness
of bead beating methods and tube types (Figure 10).
Figure 10. Agarose gel run of the genomic DNA extracted from infant (B1 – B4) and adult (A1
– A4) fecal samples using two types of bead beating tubes, commercial (RT) and self-made
(ST), bead beating methods (RBB and BB) and purification methods (automatic and manual).
In line with the fluoreometry-based DNA quantification, the presence of smears throughout the
samples extracted using self-made tubes indicated higher amount of DNA present in the
eluates. Adult fecal samples gave similar bands (>8000 bp) from both DNA extraction methods
(BB and RBB). For the infant samples, DNA extraction with commercial tubes gave 3 times
less DNA (µg) and 8 times less DNA per mg feces than self-made tubes (Figure 9 II). Similarly,
DNA bands and smears observed in the gel also indicate higher amount of DNA when using
self-made tubes and RBB method for infant samples. With readymade tubes and RBB method,
the banding pattern (in agarose gel, Figure 10) was comparable to that of self-made tubes,
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suggesting that the readymade bead beating tubes can provide sample shearing efficiency that
is comparable to that of self-made tubes.
5.3. Amplification of abundant bacteria using qPCR
To estimate the amount of amplifiable bacterial DNA in the fecal DNA extracts, 16S rRNA
gene of the most abundant bacterial groups (Bacteroidetes, Clostridium and Bifidobacteria)
and total bacteria were targeted using qPCR.
Figure 11 qPCR results for the abundant bacteria in (I) infant and (II) adult fecal DNA
extracted using Bead Beating (BB) and Repeated Bead Beating (RBB) method with commercial
(RT) and self-made (ST) bead beating tubes. Adult fecal samples were extracted using
readymade tubes and purified manually.
For the total bacteria and all tested bacterial groups in infant samples purified with automated
system, BB method gave roughly 0.3 log higher counts than the RBB method when using the
commercial tubes, while using the self-made tubes the counts were comparable to the BB
method (Figure 11 I). Amplification on manually purified adult’s fecal DNA (Figure 11 II)
extracted using readymade tubes and bead beating methods (BB and RBB) produced similar
amplification (~106 to ~107) for all the bacterial groups.
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5.4. 16S rRNA gene amplicon sequencing
Amplicons of the 16S rRNA gene (V3-V4 region) were sequenced with Illumina MiSeq
platform using infant’s fecal DNA extracted with different bead beating tubes and methods as
explained above to study their potential effects on the bacterial composition. The relative
proportions of the bacterial phyla (Figure 12 I) and the ratio of gram negative and gram-positive
bacteria (Figure 12 II) were found to be very similar between the methods, individuality driving
the between-sample (B1-B4) differences.
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Figure 12 Gram positive or negative abundant bacterial phyla obtained from infant’s fecal DNA (B1-
B4) extracted using two types of bead beating tubes (self-made and commercial) and two extraction
methods (BB and RBB)
In all samples Actinobacteria, more specifically Bifidobacteria, dominated the communitiy
with relative abundance from 50% to 90%, Proteobacteria and adult-type Bacteroidetes and
Clostridia being less abundant. Genus-level analysis indicated that both DNA extraction
methods (BB and RBB) and bead beating tubes (RT and ST) successfully extracted DNA from
both gram positive (Bifidobacterium, Anaerostipes and Streptococcus) and gram-negative
bacteria. In samples B1, abundancy of Proteobacteria was ~25% which together with
Bacteroidetes is a major phylum of gram negative bacteria within the gut microbiota. As gram
positive bacteria, containing thicker cell wall, typically account for more than 50% of the
bacteria in fecal samples, a successful extraction of DNA from these bacteria testifies the
effectiveness of used DNA extraction methods. In this study, the samples extracted with
commercial versus self-made bead beating tubes gave similar, high abundance of gram positive
bacteria (Figure 12 II).
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5.5. Commercial wash buffers vs. self-made wash buffers for purification of DNA from
fecal extracts
Commercial wash buffers (MagMax™ Total Nucleic Acid Isolation kit) used for purification
of fecal DNA extracts turned out to be insufficient for fecal samples, raising a need to develop
affordable self-made wash buffers. Newly composed self-made wash buffers were tested
against MagMax’s commercial wash buffers for their performance in high-throughput
purification (Thermo Scientific™ KingFisher™ Flex Purification System) system. Two self-
made wash buffers were prepared and tested to examine their compatibility of the system and
impact on the DNA yields and quality (Table 9).
Table 9 Different type of wash buffers tested for purification of fecal DNA extracts
Commercial
wash buffer
MagMax™
Self-made
wash buffers
Wash Buffer I HWI
HWI_E
Wash Buffer II HWII
Microbial DNA from fecal samples were extracted from adult and child fecal samples using
RBB method with commercial bead beating tubes. Self-made and commercial wash buffers
were used for purification of the same infant samples (B1-B4) as used in previous experiments
for testing of high-throughput system. The performance of the wash buffers was evaluated by
comparing the change in Threshold Cycle (Cq) against the template amount used in PCR. In
the absence of PCR inhibition, Cq decreases linearly as a function of increased amount of
template DNA (Figure 13).
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Figure 13 DNA yields obtained from extraction using different wash buffers for purification (I)
and comparison of Cq values against template amount used in qPCR (II)
The difference between DNA yields (Fig. 13 I) were minute (10.24, 10.39 and 10.48 µg/mg of
feces) among different wash buffer sets. Comparison of the Threshold Cycle (Cq) values in
Bacteroidetes qPCR showed no differences between the buffers with low template amounts
(0.5 and 5 ng). With higher input template (50 to 100 ng), some differences emerged (Fig 13
II). The EDTA-containing self-made buffer (HWI_E/II) and MagMax™ buffer showed an
expected, decreasing trend of Cqs, while the other self-made buffer set HWI/II gave
inconsistent results and no amplification was recorded for any sample when using the highest
amount of template DNA (250 ng). We concluded that at concentrations that are used for
preparation of the sequencing libraries (1-5 ng), HWI_E/II (first wash buffer with EDTA)
buffer set provided similar or better amplifications than the MagMax™ commercial wash
buffer and was hence implemented in the final protocol for purification of fecal DNA extracts
in 96 well format.
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5.6. High-throughput system for processing fecal samples
From the above-described experiments and optimizations, we established a method for the
automated DNA extraction of fecal samples based on RBB method for cell lysis, KingFisher™
Flex Purification system and MagMax™ Total Nucleic Acid Isolation Kit along with self-made
wash buffers (HWI/II and HWI_E/II). To enable bead beating in a high-throughput manner,
FastPrep®-24 homogenizer was replaced by FastPrep®-96 instrument. Following is the setup
for 96 well format high-throughput microbial DNA extraction and purification system.
DNA extraction/purification Kit: MagMax™ Total Nucleic Acid Isolation kit
DNA extraction method: Repeated Bead Beating (RBB)
Grinding, lysis and homogenization: FastPrep®-96
Incubation: VorTemp™ 56 microplate shaking incubator (56 tubes per run)
Wash buffers: Self-made wash buffer I with EDTA (HWI_E) and wash buffer II (HWII)
Reagent dispenser: Thermo Scientific™ Multidrop™ Combi Reagent Dispenser
DNA purification instrument: Thermo Scientific™ KingFisher™ Flex
DNA quantification/storage: Quant-iT™ High-Sensitivity dsDNA Assay Kit/ 96 well plates
5.7. Application of high-throughput microbial DNA extraction and purification system
5.7.1. Extraction of microbial DNA from paired infant and mother fecal samples
Fecal samples collected in the context of the JORVI study were extracted using the newly
developed and optimized high-throughput system. DNA was extracted from 60 mother-infant
pairs sampled longitudinally, the number of available samples at the time of this project totaling
to 647 samples: 342 from the mothers (mean age 33.5 years) and 292 from the infants (from
the first day until 3 months) excluding dropout samples. Of the samples, 88% had been
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collected using spatula and were easy to weigh for the extraction process and the remaining
12% had been collected using swabs and were directly soaked into PBS.
Figure 14 (I) Amount of fecal material used to extract DNA from mothers and children
samples (II) amount of DNA extracted from different sample types (feces and swabs)
250 mg is the optimum amount of starting material (feces) required to extract DNA but
depending on sample type (solid, semi-solid and liquid), the amount of starting material varied.
For adult starting material varied from 69 mg to 554 mg (semi solid feces containing fibers and
undigested foods) and in infants it varied from 51 mg to 520 mg (Figure 14 I). The mean DNA
concentrations for fecal samples from adults and infants were 74.88 ng/µl and 11.66 ng/µl,
respectively (Figure 14 II). The amount of fecal material collected using swab was evidently
very much lower than in the normal samples as most swabs had hardly any visible fecal matter.
The mean concentrations from mother (adults) and infant’s swab samples were less than 1
ng/µl (mothers: 0.058 ng/µl and infants: -2.94 ng/µl), negative concentrations are observed due
to the calculation of concentration based on amount of fluorescence detected. Due to the
scarcity of DNA in the swab samples, full length 16S rRNA gene PCR was performed on
randomly selected samples varying in concentrations to confirm the suitability of the selected
method for DNA-based bacterial analysis.
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5.7.2. 16S rRNA full length PCR for adults and infant’s fecal DNA samples
Out of 342 adult samples, 50 were collected using swabs and 31 had negative DNA
concentrations. In case of 292 infants, 267 were collected normally and 25 were collected using
swabs, amongst them ~40% (21 swabs and 97 normally collected) had negative DNA
concentrations. To confirm the presence of bacterial DNA in these eluates, several samples
with negative and positive concentrations were randomly selected and 16S rRNA gene full
length PCR was performed.
Figure 15 Agarose gel result of 16S rRNA gene full length PCR performed on adults and
children fecal DNA with different concentrations (ng/µl), extracted from JORVI study samples.
Among the tested samples, all samples gave PCR products (~1500 bp) except one adult sample
which had the highest concentration of 114 ng/µl (Figure 15). The lowest negative
concentrations (for example -6.0, -8.0 and -9.0) gave the weakest bands. All DNA extracted
from children’s fecal samples gave strong bands unlike one adult’s DNA with highest
concentration (114.0 ng/µl). Overall, strong and clear bands from all the samples enabled us to
confirm the presence of amplifiable microbial DNA in the extracted samples including those
with negative concentrations. Loading very high amount of template DNA in PCR might limit
reagents used in reaction (esp. magnesium ions to stabilize the DNA structure) and produced
less or no amplicons.
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5.8. Section 2: prevalence and abundance of Lactobacillus rhamnosus GG in a subset of
the extracted samples
This section will provide the information about the results obtained from experiments
performed towards the following objectives.
a) To understand the prevalence of L. rhamnosus GG among 3 month’s old babies from two
studies done ~10 years apart, placebo group of FLORA (n=30) and JORVI (antibiotic and non-
antibiotic group) study (n=28).
b) To study the co-occurrence of L. rhamnosus GG in mothers and their infants from birth until
3 months after giving birth.
Note: For tables and figures Lactobacillus rhamnosus GG (L. rhamnosus GG) will be
abbreviated as LGG.
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5.9. Prevalence of L. rhamnosus GG among 3-month-old infants
The prevalence of L. rhamnosus GG among 3 months old infants from FLORA study (placebo
group) and JORVI study (antibiotic and non-antibiotic group) was studied using PCR method
which targeted L. rhamnosus GG specific sortase C gene (Figure 16).
Figure 16 (I) Target region (gene) of sortase C gene present in L. rhamnosus GG (II) Agarose
gel electrophoresis to study the presence of sortase C gene as marker of L. rhamnosus GG in
3 month's old babies’ fecal DNA extracted from JORVI and FLORA studies. Sample ID A33
from active group (infants who took probiotic capsules containing LGG) of FLORA study was
included in reaction as positive (+ve) control and fecal DNA containing LGG under detection
limit as negative (-ve) control including NTC (non-template control).
In total 58 samples were analyzed and 35 (60.3%) of them were positive for L. rhamnosus GG.
A subset of samples is visualized in Figure 16 II, showing that samples 3, 7, 11, 4, 6, 18, 22,
56, 157, 160, 169 and 234 gave positive bands (150 bp) for L. rhamnosus GG.
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Figure 17 Prevalence of L. rhamnosus GG among 3 month’s old children from JORVI and
FLORA studies
Overall ca. 60 % of the studied 3 month’s old infants were positive for L. rhamnosus GG in
both JORVI study (n=28) and FLORA study (n=30). In JORVI study, number of L. rhamnosus
GG positive in both antibiotic and non-antibiotic group were 9 and 8 respectively (Figure 17).
Only infants positive for L. rhamnosus GG at 3 month’s (3m) age were selected for further
analysis and L. rhamnosus GG srtC PCR were performed on the fecal DNA extracts collected
at earlier time points, i.e. at 1 month (1m), 2 weeks (2w), 1 week (1w) and at birth (B).
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Figure 18 Prevalence of L. rhamnosus GG (LGG) in infants at different time points after birth
(B) until 3 months when all the selected 17 infants were positive for LGG.
All infants were negative for L. rhamnosus GG at the time of birth and after one week (Figure
18). At the age of 2 weeks, 3 infants and 6 infants at the age of 1 month were L. rhamnosus
GG positive. Only 1 infant was positive at the age of 1 month from antibiotic group compared
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to the 5 L. rhamnosus GG positives from non-antibiotic group. Detailed information about the
use of different antibiotics by mothers and prevalence of L. rhamnosus GG at birth and 3
months after birth is listed in Table 10.
5.10. Co-occurrence of L. rhamnosus GG in mother-infant pairs
To study the potential transfer of L. rhamnosus GG from the mother to her child, we utilized
the fact that paired mother-infant samples were available from the same time points. Only
children positive for L. rhamnosus GG at 3 months were selected for this analysis to study the
early temporal patterns. Hence, we analyzed mother’s fecal DNA from all samples (n=28) and
from all-time points, i.e. birth (B), 2 weeks (2w), 1 month (1m) and 3 months (3m) using the
same srtC PCR method as above. Comparison between the prevalence of L. rhamnosus GG
amongst the mothers and their infant’s samples collected at same time points was used to
speculate if infants get these specific bacteria from their mother.
Figure 19 (I) Positivity of srtC PCR as a marker of L. rhamnosus GG (LGG) carriage in 3-
month-old children (C; N=28) and their mother’s (M) fecal DNA samples at different time
points, from birth (B) to 3 months (3m) (II) Comparison between all the time points for presence
of LGG in mothers and their children who were all positive for LGG at the age of 3 month
(N=17).
Circa ~60% of the infants (n=28) were positive for L. rhamnosus GG at 3m whilst only ~14%
of the mothers (n=28) were positive at the same time point, and ~39% when they gave birth
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(Figure 19 I). Among the mothers of infants that were all positive at the age of 3m (n=17),
~35% were positive for L. rhamnosus GG at the time of childbirth. In other words, only 4
mothers and their child were both positive at 3m time point and 13 mothers were negative for
L. rhamnosus GG while their child was positive. Only one mother (ID# 7) was positive at all-
time points and her child was also positive at all-time points (Figure 19 II) except at birth (B).
Status of occurrence of L. rhamnosus GG among mother-infant pairs and antibiotics used by
pregnant mothers can be observed in Table 10.
Table 10 A detailed information about the use of intravenous antibiotics by pregnant mothers
during parturition (n=28) and antibiotics used by infants within 3 months after birth in JORVI
study, and occurrence of LGG at the time of birth and at 3 month for mother-infant pairs.
ID
Mothers Infants
LGG +ve
(at birth)
Antibiotics LGG +ve
(3m)
LGG +ve
(at birth)
Antibiotics
(≤3m)
LGG +ve
(≤3m)
A
N
TI
BI
O
TI
C
S
04 0 *Pen 0 0 1
06 0 Cef, Met 0 0 Amo 1
08 0 *Pen, *Cep 0 0 0
18 1 *Pen, *Cep 0 0 1
22 1 *Pen 0 0 1
26 0 *Cef 0 0 0
33 0 *Cef, *Cep 0 0 0
34 0 *Pen 0 0 1
41 1 *Cef 0 0 0
48 1 Cef 1 0 1
50 0 *Cef 0 0 1
58 1 *Unk 0 0 0
61 0 *Cef, *Cli 0 0 1
64 1 Cef, Met, Cep 0 0 1
Total 6 1 0 9
N
O
N
-A
N
TI
BI
O
TI
C
S
02 1 0 0 0
03 0 0 0 1
07 1 Cef, Met 1 0 1
11 0 1 0 1
12 0 0 0 0
13 0 0 0 1
14 0 Amo 0 0 1
17 0 Cep 0 0 1
19 1 Cep 1 0 Amo 1
20 0 0 0 0
21 0 0 0 0
23 1 0 0 0
24 1 0 0 0
28 0 0 0 1
Total 5 3 0 8
Amo- Amoxicillin, Cef- Cefuroxime, Cep- Cephalexin, Cli- Clindamycin, Met- Metronidazole, Pen- Penicillin and Unk- Unknown
* Pregnant mothers completed at least one dosage of antibiotics before birth
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5.11. L. rhamnosus GG srtC border qPCR
During the project, it turned out that the sortase C gene targeted in the above experiments using
srtC PCR for identification of L. rhamnosus GG was not fully specific for L. rhamnosus GG
and hence amplification of DNA also from other bacteria possessing the same sortase C gene
cannot be excluded. Presence of sortase C gene in different species of lactic acid bacteria
(Lactobacillus casei, Lactobacillus paracasei and Lactobacillus rhamnosus) have questioned
the previous detection method for identification of specific Lactobacillus rhamnosus GG strain.
For accurate identification of L. rhamnosus GG present in fecal DNA extracts, this new qPCR
assay (srtC border) targets the border of L. rhamnosus GG specific gene and partial sortase C
gene (Figure 20).
Figure 20 Difference between target regions used in PCR and qPCR for identification and
quantification of L. rhamnosus GG.
Vigorous testing and validations were performed for optimization of new L. rhamnosus GG
detection and quantification method. Fresh L. rhamnosus GG standards were prepared from
genomic DNA (standard L. rhamnosus GG count: 6.12E+05 cfu/µl) extracted from pure
cultures in De Man, Rogosa and Sharpe (MRS) broth and plates with manual grid counting of
colonies. Six serially diluted standards were optimized and used to identify and quantify L.
rhamnosus GG from microbial DNA extracted from children fecal samples collected during
JORVI (n=28) and placebo group of FLORA (n=30) studies.
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Figure 21 (I) Comparison between the number of  L. rhamnosus GG  positive samples between
the old assay (LGG srtC-PCR) and new assay (LGG srtC border qPCR) on selected 3 months
old children samples from JORVI and FLORA study (II) Scattered plot showing the average
count (with standard deviation) of LGG detected with the new qPCR assay (LGG srtC border)
against threshold cycle (Cq) value on samples from 3 month old children in FLORA (n=30)
and JORVI (n=28) study, along with standard LGG genomic DNA and water as non-template
control (NTC.)
Among FLORA samples (n=30), ~60% tested positive using the old PCR method, while only
~33% were positive using the new srtC border qPCR method (Figure 21 I). In other words, the
number of positive samples decreased by ~50%, indicating high ratio of false positive results
with the old PCR assay. There were no significant differences in positives among JORVI
samples (n=28), 2 children in antibiotic group who were positive when tested with the old
method were negative with qPCR. Only 58 samples were analyzed with this new method
excluding all other time point samples from mothers and their child, thus we did not get a
complete analyzed result like from end point PCR method, due to which we are limited to use
the non-reliable result from old unspecific method.
The new qPCR method enabled also quantification of L. rhamnosus GG in the samples. The
quantity of L. rhamnosus GG detected from different study groups varied significantly. The
average number of bacteria (calculated per 1 ng template DNA) detected from FLORA, JORVI,
LGG genomic DNA and NTC were 236, 2, 367 and 0 respectively (Figure 21 II). The copy
numbers ranged from 0.02 to 1715.4, indicating that this highly sensitive method can detect up
to one L. rhamnosus GG cell present in the fecal DNA extract. The Cq values greater than 29.0
were considered as negative (as in NTC) since no L. rhamnosus GG were detected after 29th
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qPCR cycle. Pure L. rhamnosus GG’s genomic DNA crossed the threshold after 18th cycle.
Few amplified samples, using PCR and qPCR, were randomly selected and sent to Sanger
sequencing. The sequences derived from the old assay gave multiple BLAST hits in contrast
to the limited hits with the new assay (Table 11) as expected.
Table 11 Primer details and BLAST hits obtained for sequences of PCR amplicons generated
with the two L. rhamnosus targeting assays specified in the text.
Assay LGG srtC PCR LGG srtC_border qPCR
Primers Fwd- AGTGCGACTATTAGCTTTA Fwd- CATTCATGTTGCATCGTCCT
Rev- GGATCTTGTGACCTTAATG Rev- GCTTGGCCGGACTAAGTACA
Hits Bacteria Strain Bacteria Strain
Lactobacillus
paracasei
IIA Lactobacillus casei LOCK919 Plasmid pLOCK919
KL1 Lactobacillus rhamnosus WQ2L9 GG, ATCC 53103
CAUH35
N1115
S.sp. paracasei 8700:2
S.sp. paracasei JCM 8130
ATCC 334
Lactobacillus
casei
Zhang
12A
W56
BD-II
LC2W
BL23
LOCK919
Plasmid pLOCK919
Lactobacillus
rhamnosus
WQ2
GG, ATCC 53103
The old assay (LGG srtC PCR) targets only sortase C gene (srtC) and in addition to L.
rhamnosus GG had also detected multiple strains of L. casei and L. paracasei, which makes
this assay unspecific. The new qPCR method was specific to two strains of L. rhamnosus (WQ2
and GG) and a 29,768 bp plasmid pLOCK919 from L. casei. This results indicate that the newly
tested qPCR method substantiated the specific detection and quantification of LGG from child
and adult’s fecal DNA extracts.
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6. DISCUSSION
6.1. Development of a fecal sample collection system that circumvents the need for sample
aliquoting prior to DNA extraction
Collection of fecal samples and their appropriate storage until further processing is a critical
step in conducting human microbiome studies. Maintaining the natural integrity of sample is a
must to avoid biased microbiota results, where slight interference can question the quality of
the outcome (Choo, Leong, and Rogers 2015). In this study, among the four different collection
methods tested for infant fecal samples, coffee stirrers became the best option simply due to
length of the stick, easiness in handling and convenience in collection of fecal scoops except
for watery samples, which need to be collected with cotton swabs.
No standard quantity of fecal matter have been defined for DNA extraction, the amount ranges
from 25 to 200 mg depending upon extraction procedures (Mirsepasi et al. 2014; Wesolowska-
Andersen et al. 2014; Hart et al. 2015). Our protocol instructs parents to collect a minimum of
~250 mg of infant feces, which is required for the modified RBB DNA extraction method, and
hence provides a “ready-to-use” sample for DNA extraction without the need for aliquoting the
samples. The entire collection tube is weighed to record the sample weight for further
calculations, in this manner the time it takes to thaw samples after -80°C storage can be utilized
for weighing. Then the entire sample is homogenized with PBS, without a backup for crude
feces, which is a downside of this system. Hence, duplicate sampling is recommended if crude
fecal matter is needed after DNA extraction from the samples. The current technique suits well
to a high throughput system because the labour intensive sample weighing step is eliminated
and hence the sample preparation time could be reduced as much as by ~50% while maintaining
the required cold chain throughout the process, from the sample collection until DNA
extraction.
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6.2. Optimization of key parameters for high throughput fecal DNA extraction: Bacterial
cell disruption by bead beating and purification and quantification of DNA
An optimum fecal DNA extraction system should efficiently deliver high quality DNA that
accurately represents the original bacterial community. The system is considered high
throughput if it can process large number of samples at once, typically in a single run using
semi-automated or fully automatic systems. In our newly validated and optimized high
throughput fecal sample processing system, thawed fecal samples undergo mechanical
disruption for release of the bacterial DNA in the presence of lysis buffer. In this work, we
studied the effect of bead beating tubes and protocols on the fecal DNA yield.
We first studied how the performance of the self-made tubes (ST) that had a long history of
use in the laboratory as part of the manual method compare to that of the readymade tubes (RT)
that are needed for the high throughput DNA extraction. With ST, the DNA yield was over 6-
fold higher (376.25 µg/mg vs 59.707 µg/mg) from children’s samples. The major difference
between RT and ST is the volume of the tubes and the starting amount of fecal material used
in the extraction. In ST it is ~125 mg and in RT only 14-20% (175 µl) of homogenized fecal
suspension (~250 mg of feces in 500 µl PBS for infants and 1000 µl for adult samples) fits in
the tube. Despite the better performance of the STs, they were not a realistic option for high
throughput DNA extraction system as manual dispension of the beads for hundreds and
thousands of samples is not feasible. As we were unable to find RT with larger volume than
the ones we tested, and their DNA yield was sufficient for the downstream analyses, they were
selected for further use.  However, any comparisons to be made between the DNA yields of
the manual and automated DNA extraction protocol in question should acknowledge the strong
influence of the differently sized bead beating tubes as part of the protocol.
Our tests indicated that the readymade tubes as part of the selected DNA extraction kit were
suitable for extraction of microbial DNA from adult and baby fecal samples. Despite the
decreased DNA quantity (lower DNA yield and bacterial counts in qPCR), the readymade tubes
proved to provide fecal DNA that qualitatively compared well to the manual system; they were
efficient in breaking down also the hard-to-lyse gram positive bacterial cells and produced a
representative DNA profile based on the sequencing results. As the bead beating methods
(RBB vs. BB) did not yield observable differences in the tested infant samples, we decided to
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stick, for consistency, to the RBB protocol that we have previously shown to be superior for
adult samples in terms of the species representativeness in fecal microbiota profiles (Salonen
et al. 2010).
Using prefilled bead tubes reduces the extra effort and time required to weigh and manually
fill tubes with autoclaved beads. Along with the tubes, KingFisher’s automatic purification
method drastically reduced the hands-on and overall time required to purify 96 samples
compare to the manual purification method. Thus, the use of commercial bead beating tubes,
RBB method and automatic purification system provided good quality fecal DNA with
significantly higher throughput.
Disruption of bacterial cells to release DNA is completely dependent upon the type of cell
structure, especially the cell wall. For an effective breakdown of cell wall, freezing and thawing
prior to bead beating have also been very effective and results in higher yield of DNA along
with the strong mechanical disruption (bead beating) method (Bahl, Bergström, and Licht
2012; Guo and Zhang 2013), but in this project no tests were conducted to test the effect of
freezing as in clinical trials all samples need to be frozen anyway in order to process them in
large batches. There are reports showing effects of freezing fecal samples on bacterial
community, especially on two bacterial groups Firmicutes and Bacteroidetes, the ratio of which
seems to increase amongst frozen samples when compared against non-frozen (Bahl,
Bergström, and Licht 2012). Similar increase in ratio of in bacterial gene copies of Firmicutes
and Bacteroidetes were observed in study performed by Metzler et al., while both DNA yield
and microbial diversity were increased when extracted using bead beating methods (Metzler-
Zebeli et al. 2016; Knudsen et al. 2016). Use of bead beating will primarily increase the DNA
yield due to breakdown of microbial cell wall (Smith et al. 2011) from both gram positive and
gram-negative bacteria. The RBB protocol implemented in this study involves two rounds of
bead beating in lysis buffer, where the remaining intact cells from the first round undergo
another round of bead beating after incubation at 95 °C, which altogether provides enough
physical stress for a successful breakdown of most bacterial cells. Withdrawing the cell lysate
after the first round of bead beating ensures no further damage to already released DNA. As
previously shown for adult samples (Salonen 2010), RBB method facilitates efficient
extraction of DNA from archaea, Clostridium cluster IV and other hard-to-lyse bacteria.
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Subsequently we tested self-made wash buffers against commercial wash buffers used in
purification of DNA with aim of circumventing the need to purchase extra bottles of expensive
commercial wash buffers that are needed for each DNA purification run in 96 well format using
the MagMAX Pathogen High Vol Duo protocol in KingFisher Flex automat. Determining the
composition of wash buffers was another hurdle. Composition of commercial wash buffers
were not disclosed by the company (MagMAX™) thus we went through the available
literatures and finally one standard composition was devised and tested for its effectiveness.
The composition included Sodium Acetate (Na-Ac), EthyleneDiamineTetraaceticAcid
(EDTA), Tris Hydrochloride (Tris-HCl) and ethanol (EtOH). Including Sodium Acetate (Na-
acetate) in wash buffer would help to separate higher molecular DNA and polysaccharides,
neutralize base from denaturing step along with proteins, lipids and phosphate backbones,
moreover it provides buffering over the use of normal salt like NaCl (Dellaporta, Wood, and
Hicks 1983; Tan and Yiap 2009; OpenWetWare contributors 2016). The pH of Na-Ac was
maintained at ~5.2 as suggested by different sources and to perform above spoken activities
pH 5.2 was found to be the optimum one. Similarly, addition of EDTA in our buffer has already
produced positive results and its use has fulfilled its purpose. Briefly, EDTA binds with
Magnesium (Mg) ions (a co-factor for enzyme DNase) and prevent DNases to degrade DNA.
Meanwhile use of Tris-HCl along with EDTA eventually helps to maintain the buffer’s pH
near to 8.0 restricting DNase’s activity at pH 7.0 (Durst and Staples 1972; Dellaporta, Wood,
and Hicks 1983; Yagi et al. 1996b; Somma and Querci 2004). Ethanol is commonly used for
precipitating DNA by desalting (removal of carry over salts from previous steps) and
minimizing solubility unlike when dissolved in water (Piškur and Rupprecht 1995; Zumbo
2012). Finally, three wash buffers were formulated, wash buffer I with and without EDTA and
wash buffer II, pH of buffer was maintained between 7.5 and 8.0 like that of Magmax™
(commercial buffer).
Our tests revealed that the self-made wash buffers could replace expensive commercial wash
buffers. DNA yields from commercial and self-made wash buffer were similar (Magmax-
10.24 µg/mg, HWI/II- 10.39 µg/mg and HWI_E/II- 10.48 µg/mg of feces). Additionally, based
on qPCR-derived threshold cycle (Cq) values (Nechvatal et al. 2008), the PCR performance of
the purified DNA preps were similar for Magmax™ and self-made wash buffer with EDTA
(HWI_E and HWII) while DNA purified with self-made wash buffer without EDTA (HWI and
HWII) gave inconstant results and failed to amplify with the highest template amount (250 ng).
The only difference between the self-made wash buffers is presence of EDTA and as in the
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presence of EDTA, both the DNA yield and PCR-compatibility of the preps were comparable
to that of commercial wash buffer, we decided to use exclusively self-made wash buffers in the
DNA extraction protocol.
For high throughput and accurate quantification of extracted DNA, fluorometry-based
quantification was used, Qubit® (low scale) and Quant-iT™ (96 well format) over
NanoDrop™. Basically, NanoDrop™ measures anything that can absorb 260 nm light like
single and double stranded DNAs, RNAs, proteins and other constituents including
contaminants, while both Qubit® and Quant-iT™ detects fluorescence from double stranded
DNA only with sensitivity of detection down to 0.2 ng. Additionally, Quant-iT™ method
qualifies for high throughput system as it measures DNA concentrations of 96 samples
simultaneously within 30 minutes. Thus, the sensitive and accurate fluorometric methods
Qubit® and Quant-iT™ were selected for quantification of fecal DNA as part of the novel
sample processing protocol.
6.3. Amplification of abundant bacteria with qPCR and 16S rRNA gene amplicon
sequencing from fecal DNA extracted using different bead beating tubes and purification
methods
We evaluated the effectiveness of DNA extraction methods and their constituents using qPCR
method to amplify abundant bacterial genera along with total bacteria (Salonen et al. 2010; De
Gregoris et al. 2011). From children’s fecal DNA, the combination of readymade tubes with
RBB method, i.e. the one selected for the final protocol, gave ca. 0.3 log lower amplifications
for total bacteria and all the tested bacterial groups (Bacteroides, Clostridium and
Bifidobacterium) compared to readymade tubes with BB method, or self-made tubes with RBB
method (Figure 11). Reasons behind such differences in qPCR amplifications remain unknown
and due to limited time, further extensive testing were not performed. For adult’s fecal DNA
samples that were purified with manual system, there were no differences in amplifications
amongst the tested extraction methods (BB and RBB) performed with readymade bead beating
tubes.
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Comparison of the qPCR results for Bifidobacterium, Clostridium and Bacteroides between
manually purified adult samples and automatically purified infant’s samples indicated that
adult samples had lower bacterial copy numbers when equal amount of bacterial DNA was
used in qPCR reaction. This is unexpected as adult samples are expected to have higher counts
of Clostridium and Bacteroides. As the qPCR tests were designed to compare DNA extraction
conditions within a sample type (adult or child), it remains unclear if the detected differences
are biological or reflect the different PCR performance of manually and automatically extracted
DNA. Manually purified adult’s DNA using silica columns likely contains more PCR-
inhibitors than the children’s samples purified using automated system based on paramagnetic
beads, possibly explaining the lower copy numbers (less efficient amplification) of adult
samples.
To obtain a community-wide assessment of the different DNA extracts, 16S rRNA genes from
children’s fecal DNA (purified automatically) were amplified and sequenced perform
qualitative evaluation for extracts resulting from the combination of readymade bead beating
tubes and RBB method as part of the high-throughput DNA extraction and automatic
purification system. The analyzed 16S rRNA V3-V4 amplicons revealed numerous genus level
taxa that were grouped into the dominant phyla, i.e. 2 gram-positive phyla Actinobacteria and
Firmicutes, and 2 gram-negative phyla Bacteroidetes and Proteobacteria. There were no
differences in the abundancy pattern between the different extraction methods (with different
tubes and methods), and the individual differences in the microbiota compositions were
accurately reproduced with all the tested methods.
6.4. Fecal DNA extraction from adult and infant samples
The newly validated and optimized fecal DNA extraction system was then applied to process
samples from a clinical trial. In total 634 fecal samples from mothers (n=342) and their infants
(n=292) were extracted using new high-throughput extraction and purification system. The
concentrations of the extracted DNA samples varied extensively depending on the individual
and upon the amount of fecal samples available for the extraction. The samples collected using
swabs gave the lowest amount of DNA (in average 0.058 ng/µl for mothers and -2.94 ng/µl for
children. Although the average amount of fecal material used in extraction were very similar
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(~300 mg) for both adults and children, the amount of extracted DNA was much less for the
children; on average 0.5 µg per extraction from ≤ 3 month old infants and 3.7 µg per extraction
from the adult samples. This likely reflects the ongoing colonization in infants (Moughan et al.
1992; Koenig et al. 2011; Matamoros et al. 2013; Munyaka, Khafipour, and Ghia 2014) and
possibly also the different sample consistency.
Due to the lower DNA yield from children’s fecal samples, RBB microbial DNA extraction
protocol was modified after the pilot experiments to make children fecal samples more
concentrated for the extraction procedure. To this end, all infant’s fecal and swab samples were
homogenized with 500 µl PBS instead of 1000 µl used in adult samples. In total half (~50.5%)
of the extracted DNA had negative concentrations; ~10.2% of adult swabs and ~40.4% children
samples including swabs. Before proceeding with the majority of the extractions, we performed
16S rRNA gene full length (~1500 bp) PCR for a subset of the extracted DNA samples with
concentrations ranging from negatives to very high positive. The positive PCR results gave
supportive evidence for the presence of enough DNA for molecular microbiota analysis in most
samples and justified the use of the developed extraction and purification method. In defense
of the negative concentrations, the use of 1 µl of the original DNA eluate and diluting it 200
times during quantification with Quant-iT™ might not have been enough to contain sufficient
DNA molecules to produce detectable fluorescence from dsDNA and thus resulted in negative
concentrations when compared against standards. The modification in the protocol by using
500 µl PBS for homogenization of infant’s fecal samples, better DNA yields and concentrations
were obtained. With the success after the protocol’s modification it has been successfully
implemented in HELMi study (large scale microbiota study) in Finland.
6.5. Prevalence and persistence L. rhamnosus GG among 3 month’s old children and co-
occurrence in mother-infant pairs
Lactobacilli are the most common probiotic bacteria, which possesses many health benefits
(Lebeer, Vanderleyden, and De Keersmaecker 2008). Specifically L. rhamnosus GG (ATCC
53103) have become a widely studied probiotic bacterium and several studies (Doron,
Snydman, and Gorbach 2005; Kankainen et al. 2009; Rasinkangas et al. 2014) have reported
its persistence in human (children and adults) gut as well as health benefits. In this study we
65
studied its prevalence and persistence among 3 month’s old children and its co-occurrence in
mother-infant pairs sampled on the same days.
After completing the L. rhamnosus GG experiments on the selected samples using the sortase
C specific end-point PCR (Table 11), it turned out that this assay is not fully specific for L.
rhamnosus GG but instead amplifies DNA also from some other closely related lactobacilli
(see section 6.7). After development of the new qPCR based assay, the 3 month samples from
JORVI and FLORA studies were used to validate the new assay (Figure 21). Unfortunately,
due to time limitation for this master’s thesis project it was not feasible to re-run all the samples
with the qPCR assay. Hence, the L. rhamnosus GG results are mainly discussed based on the
results of the end-point PCR that was performed in all selected samples.
At the time of childbirth, ~39% of the mothers were positive for L. rhamnosus GG, while none
of the infants were positive during the first two weeks of life. On the other hand, at 3 months,
~60% of the infants were positive while only ~14% of the mothers were positive. From this
unsynchronized outcome it can be concluded that the mother is not the primary route for the
neonate for acquiring L. rhamnosus GG. For this asynchrony other factors, such as the use of
probiotic products and antibiotics as well as the low DNA yields from infant samples, come
into play.
The intake of L. rhamnosus GG as a probiotic supplement is the most obvious source of this
bacterium in the feces. During daily intake, adults secrete ca. 108 genome copies of L.
rhamnosus GG per gram of feces (Kekkonen et al. 2008). In this project, although the use of
probiotic products was recorded in the clinical trials from where a small subset of samples was
used in this study, the data were not collected in such detail that it would enable accurate
comparison of L. rhamnosus GG intake versus excretion, especially regarding the actual
duration and timing of probiotic intake in relation to fecal sampling. Accordingly, the use of
binary data (yes/no) on the probiotic use before fecal sampling (Table 2) proved to correspond
poorly to the presence of L. rhamnosus GG in the fecal samples.  For example, at 3 months,
none of the mothers who took probiotics containing L. rhamnosus GG (5/28) were positive in
the PCR. In the case of children, ~57% (16/28) were given probiotics containing L. rhamnosus
GG and among them, ~62% (n=16) were positive.
With the reliable qPCR assay, more than every second (57%) 3-month-old infant tested positive
for L. rhamnosus GG in the recent JORVI study. Collectively, these data reflect active probiotic
use during perinatal period in the current society. On the other hand, as high as 30% of the 3-
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month-old infants in the control group of the FLORA study, conducted over a decade ago, were
also positive, although the control group is advised not to use any probiotic products
immediately before and during the intervention period. Our results are in line with those of a
probiotic intervention trial in adults; despite the 3-wk run-in with probiotic restriction, a
detectable level of L. rhamnosus GG was detected in a subset of subjects at baseline (Kekkonen
et al. 2008). This is because in Finland probiotic use is highly common (Saxelin 1997) and
staple foods such as yoghurts can contain probiotic bacteria so that they are consumed
unintentionally (Ouwehand, Saxelins, and Salminen 2004).
The fact that a single infant was not positive for L. rhamnosus GG before the week 3 after birth
may have explanation related to microbial ecology. L. rhamnosus GG is a facultative anaerobe
and a newborn’s gut is inclined towards facultative aerobes before the pioneering aerobes
consume the prevailing oxygen (Houghteling and Walker 2015). Hence, it likely takes a while
for L. rhamnosus GG to flourish in a neonatal gut. In addition, Goldin et al. have reported that
for a successful detection of L. rhamnosus GG it takes at least a week after the beginning of
intervention in adults (Goldin et al. 1992; Guaraldi and Salvatori 2012). Meanwhile, from an
intervention study conducted among 2 to 7 years old children, Korpela et al. have described
the successful alteration in intestinal microbiota after uninterrupted consumption of L.
rhamnosus GG for 7 months (Korpela, Salonen, Virta, Kumpu et al. 2016). Thus, it likely takes
some time for L. rhamnosus GG to prevail in unfavorable infant’s gut despite its reported
ingestion at earlier time points.
Based on literature, transfer of L. rhamnosus GG from mother can also happen via mother’s
milk (Ballard and Morrow 2013) and in both studies (FLORA and JORVI) exclusively
breastfed infants (~31%) were more often positive for L. rhamnosus GG compared to those
who were formula-fed (~12%). Similarly, antibiotics have also been reported as influencing
factor in colonization and prevalence pattern of microorganisms including on L. rhamnosus
GG (Korpela, Salonen, Virta, Kekkonen et al. 2016; Korpela, Salonen, Virta, Kumpu et al.
2016; Langdon, Crook, and Dantas 2016). Following the antibiotics intervention in JORVI
study, among 11 mothers from antibiotics group (n=14) who completed their antibiotics dosage
before giving birth, 5 were positive for L. rhamnosus GG at birth while only 1 was positive at
3 months, and in non-antibiotics group (n=14), 5 mothers were positive at the time of birth and
3 at 3 months. In case of infants (n=28) who did not take any antibiotics until 3 months, none
were positive for L. rhamnosus GG at birth while 17 became positive at the age of 3 months.
With the limited information about only intravenous antibiotics used during parturition and
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their use during different time points limits us to get to a conclusion. Only with detailed study
of the effects of those antibiotics on L. rhamnosus GG could produce a valuable result.
Looking at the technical part, it should be noted that the comparison of the multiple timepoints
from mother-infant pairs for L. rhamnosus GG carriage was based on the end-point PCR that
turned out not to be fully specific from the targeted strain. Hence, while the data may contain
false positives, we also cannot exclude that some infant samples from JORVI study remained
below the detection level due to the low DNA yield, and hence are false negatives. In addition,
studying prevalence of bacterium that is known to bind intestinal mucus (Kankainen et al. 2009;
Rasinkangas et al. 2014) using fecal samples have also been questioned since Alander et al.
have explained that L. rhamnosus GG persists for longer periods in the colonic mucosa layer
even when not detected in feces (Alander et al. 1999). Overall, the focus area of this project
was in the development of high throughput fecal sample processing system, its application for
the first time for samples derived from a clinical trial, and confirmation that the resultant DNA
is suitable for bacterial analysis. The results of L. rhamnosus GG analysis helped us to identify
the points for further improvement, more specifically the need for higher input (which
eventually gives more concentrated samples) of infant fecal samples for sufficient DNA yield,
as well as the need for better method for detection of L. rhamnosus GG. Hence, a broader
discussion and speculation on the factors that underlie the biological outcome of the L.
rhamnosus GG results is out of the scope of this project and instead are justified for another
study which has larger sampler size and that is free from technical confounders related e.g. to
low DNA yield and assay specificity.
6.6. New specific identification and quantification real-time detection method to replace
old unspecific method for identification of L. rhamnosus GG
A side project was also going on during this project, a new alternative approach was being
developed for specific identification and quantification of L. rhamnosus GG that could replace
old screening method (Table 11, sortase C specific end-point PCR). Incorrect identification of
bacteria and outcome from any research is unreliable, Hamilton and Shah have also shown the
methods that have misidentified different strains of bacteria including L. rhamnosus GG
(Hamilton-Miller and Shah 2002). With known characteristics of L. rhamnosus GG’s pili
(containing mucus binding protein) and role of different sortases (SrtA and SrtC) (Kankainen
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et al. 2009; Douillard et al. 2014) have led us to use SrtC gene in development of new detection
and quantification method for L. rhamnosus GG. New specific real-time identification and
quantification method (qPCR) for L. rhamnosus GG targets section containing partial genomic
and sortase C gene, which proved to be a reliable and robust method instead of targeting only
SrtC gene (Figure 20 and 21). Results confirmed from the blast hits of sequences proved this
new method’s specificity and reliability over old method. Old method’s target gene produced
multiple blast hits from L. casei and L. paracasei along with desired L. rhamnosus GG but new
real-time detection method showed specificity to two strains of L. rhamnosus GG and a
plasmid, which clearly is very specific to L. rhamnosus GG. Along with specific identification,
quantification was also possible with this new method. This gives us enormous advantage over
old PCR method. To understand the reliability of this new method same fecal DNA samples
from 3 month’s old children from JORVI (n=28) and FLORA (n=30) were analyzed and the
outcome was shocking, which led us to question our results. Briefly, only 10 children were
positive in case of FLORA samples while 18 were positive when analyzed with old method. In
JORVI new method showed 16 positives than old method which gave 17 positives. With these
differences, old unspecific and unreliable detection method was successfully replaced by new
reliable method, and it has already been heavily used in new studies.
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7. CONCLUSION
Our primary objective to establish an efficient fecal sample processing system for large-scale
microbiome studies, including an up-scaled method for extraction of high quality microbial
DNA using repeated bead beating method in high throughput manner (96 well format) have
been achieved. Use of self-made lysis and washing buffers and automatic DNA purification
method gave similar quality and quantity of microbial DNA to that of commercial one. This
newly developed system has proven to yield high quality DNA from 96 samples within 6 to 8
hours with 3 to 4 hours of pre-processing, depending upon fecal sample types (liquid, semi-
solid or solid). The protocol has been in use since its set up in de Vos/Salonen laboratory, and
is being extensively used especially in a large cohort study known as HELMi (Health and Early
Life Microbiome) in Finland. The use of self-made buffers during DNA extraction is not only
economical but also ensures that the same protocol is available in longitudinal studies where
the first and last samples can be sampled and processed several years apart, during which
changes in the composition of commercial buffers can take place.
In this project, microbial DNA from 647 adults and children (≤ 3 months) fecal samples from
JORVI study were successfully extracted with the newly established high throughput system.
Of those, samples from birth to 3 months from 28 mother-infant pairs were randomly picked
to test the suitability of the DNA extracts for PCR-based downstream analysis, and to set up a
pilot study for understanding the prevalence of L. rhamnosus GG in neonates and their mothers.
While we made some attempts to relate the results on L. rhamnosus GG to the available data
on antibiotic and probiotic use, the L. rhamnosus GG results presented in this study must be
interpreted with caution. This is due to the fact the data may contain both false positives and
false negatives, because the applied end-point PCR method turned out to be somewhat
unspecific, and some infant’s samples yielded minute DNA yields, respectively. Hence,
another study is required to properly study the prevalence of L. rhamnosus GG and factors
affecting it, building on the methods developed and validated in this thesis, i.e. the specific
qPCR assay as well as the DNA extraction method that was further optimized for infant
samples by increasing the sample input. Hence, although the biological relevance of the current
results on the prevalence of L. rhamnosus GG is limited, by identifying the pitfalls of the
original study, set up the results of this project further contribute to the technical evaluation
and validation of the targeted protocols.
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Appendix A- Instruction for Infant’s fecal sample collection using wooden
coffee stirrer stick
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Appendix B- Extraction of Nucleic Acid from 96 fecal samples using
Repeated Bead Beating (RBB) with KingFisher Flex 96 (High throughput
Protocol)
Using Ambion Bead Tubes and following Magmax™ Protocol
Note: Use Ice Box to keep the samples in between the various steps, do not keep them in room
temperature for longer time
* Reagents available in Kit (Ambion, MagMax™ Total Nucleic Acid Isolation Kit, AM1840)
Machine: KingFisher Flex, ThermoScientific™
Read all the instruction thoroughly before starting
A. Preparation of Lysis (RBB) buffer
Stock Dilution (fold) Final conc. Amount (ml)
1M Tris-HCl 20 0.05M 5
0,5M EDTA 10 0.05M 10
5M NaCl 10 0.5M 10
20% SDS 5 4% 20
Water (MQ) - - 55
Total 100
Prepare stock solutions beforehand
RBB required: 635 μL per sample (61 ml for 96 samples)
Preparation of RBB: Mix well until clear solution is observed (May require hot water (max 700C) bath
to warm the solution) and Store RBB buffer in room temperature.
Usage: If solution precipitates warm the solution in water bath (max 700C) to get clear solution
B.  Preparation of Nucleic Acid (NA) Bead mix* for final extraction
Each DNA isolation reaction requires 20 μL of Bead Mix per sample. Although the mixture is stable at
4°C for up to 2 weeks, we recommend preparing it on the day it will be used.
Add 360 µl Carrier NA* (Comes with kit) or Nuclease Free water to the 28 ml Lysis/Binding
Enhancer* before mixing with NA Binding Beads*. Lysis/Binding Enhancer is now stable for
month and can be stored at room temperature.
Component Per reaction (μL) 96 rxns (μL)+ 1 extra rxn
NA Binding Beads* (Vortex before using) 10 970
Lysis / Binding Enhancer* 10 970
Total 20 1940
The bead mix can be stored at 4°C until used (Vortex well before using)
Protocol continues to next page
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C. Preparation of 1X PBS pH 7.4 (Note: Readymade 1X PBS can also be used from Kit)
Stock Dilution (fold) Final conc. Amount (ml)
10X PBS 10 1X 10
Water (MQ) - - 90
Total 100
Mix well and store at room temperature
D. Isopropanol (No need to prepare Just ensure the required amount before starting the
extraction)
Isopropanol is required for the final NA (Nucleic Acid) extraction process and 300 μL is required per
sample.
E. Preparation of Wash Buffers for DNA purification
(Wash Buffers should be ready before starting extraction process)
To prepare wash buffers: Go to section H
Wash Buffers constituents
Wash Buffer 1
HWI_E
Stock Final Volume (ml)
Na-acetate pH 5.2 3M 0.3M 6.5
EDTA 0.5M 10mM 1.3
Ethanol 96 % 70 % 57.2
Total 65
Wash Buffer 2
HWII
Stock Final Volume (ml)
Tris-HCl pH 8 1M 10mM 1
Ethanol 96 % 70 % 99
Total 100
Note: If Wash buffers precipitates prepare again
Protocol continues to next page
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F.  Disruption of Solid Samples (Feces sample) and collecting supernatants (Follow the
steps from 1 to 4)
1. Weigh ~0.25 g sample (Feces) and mix with PBS
a. Weigh ~0.25 g (±0.05 g) sample to the 2ml Eppendorf Tube
b. Pipette 1 mL of 1X PBS (pH 7.4) into the sample tube for Adult feces samples and 0.5 ml 1X PBS
(pH 7.4) for baby feces samples
c. Mix by vortexing (vertically and horizontally) at moderate to high speed until the sample is fully
suspended (Homogenized)
Note: The Vortemp 56 (Incubator) can only fit 56 sample tubes so it’s wise to process 48 (half
plate) samples for first round of bead beating followed by preparation of another set of 48
samples.
3. Centrifuge at 100 x g for 1 min
a. Centrifuge fecal samples (Homogenized with PBS) at very low speed, 100 x g (971 rpm), for 1 min
(Note: step 2 and 3 can be done at the same time)
b. Transfer 175 μL of the supernatant into each Bead Tube (Step 1) containing RBB Buffer Solution
(Total volume 410 μL) Continue to section F 4.0 and step IV
2. Add 235 μL Lysis buffer (RBB) to Beaded Tubes
Dispense 235 μL RBB Buffer into Beaded Tubes (Ambion) with fecal supernatant (From Step 2) for
each sample.
Perform the Repeated Bead Beating
Protocol continues to next page
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4. Perform Repeated Bead Beating
Note: Be prepared with well labelled KingFisher deep well 96 plate for collection of supernatants (S1
and S2) and meanwhile set the water bath or Vortemp 56 (labnet) at 950C for the incubation before
starting the bead beating.
Follow the following procedure for repeated bead beating (RBB)
Steps Procedure
I Use FastPrep®-96 (MP) at speed 800 rpm for 60 seconds (After 60 second run let samples
and machine cool down for 5 min, Samples can remain at Room Temperature) and repeat
the fast prep for 2 more times
II Incubate the tubes at 95°C for 15 min with gentle shaking (Vortemp 56)
III Centrifuge at RT for 5 min at full speed (to pellet the solid particles) and Transfer ~300 ul
supernatant (S1) into deep well 96 plate (Remember: avoid pipetting beads into the
supernatants) and seal the plate unless required.
IV Add 100μL of fresh lysis (RBB) buffer to the same bead beating tube with pelleted feces
and repeat the whole process from Step I to III and Transfer all (Final) the supernatant
(S2) (Use same deep well 96 plate to collect both supernatants)
V Collect both Supernatants (S1 and S2) in same plate and seal the plate unless required for
purification. Plate can remain in room temperature at least for 30 minutes while preparing
the plates for purification. Important note: If purification cannot be started immediately,
plate with supernatants can be sealed and stored in +4°C until plate is required for
purification process and due to the precipitative nature of RBB buffer when placed long in
room temperature or in cold temperature it is highly recommended to start the purification
process as soon as both supernatants are collected. If supernatants start to form pellets
transfer the deep well plate into the warm water bath to resuspend the supernatants
completely.
Follow the Automated Nucleic acid Extraction protocol using KingFisher FLEX, ThermoScientific
(Section G)
Protocol continues to next page
87
G. Automated Nucleic acid Extraction protocol using KingFisher FLEX,
ThermoScientific
Manual: https://www.thermofisher.com/us/en/home/life-science/dna-rna-purification-
analysis/automated-nucleic-acid-purification/kingfisher-nucleic-acid-protein-purification-
systems/kingfisher-flex-system.html
*Kit: Ambion (life technologies) MagmaxTM Total Nucleic Acid Isolation Kit
Follow the following steps to extract the Nucleic acid from Bead beated samples
Preparing Plates For extracting and purifying 96 samples
Note: Prepare following plates 10-20 minutes before transferring them to the machine
Pipette the reagents into the 96 well plates as indicated below using MultiDrop Combi,
ThermoScientific
Plate type Plate code Samples and reagents VOLUME (μl)
Deep well WashI_1 1st wash I
HWI_E 300
Deep well WashI_2 2nd Wash I
HWI_E 300
Deep well WashII_1 1st Wash II
HWII 450
Deep well WashII_2 2nd Wash II
HWII 450
Standard Elution (E) Elution Buffer* 50
Standard TIP TIP (Just put on the standard plate)
Deep well Sample Bead Mix* (pipette manually) 20
Isopropanol 300
RBB 300
*Reagents used from Kit
Note: Label the elution plate carefully since the extracted Nucleic acid can be directly stored into -200C
Prepare the Sample plate for the machine:
Mix and transfer 200 μL of the supernatants (S1 and S2) collected in deep well 96 plate after bead
beating in step 4 into the sample plate prepared above (plate code: Sample).
All required plates are prepared at this step
Turn the machine (KingFisher FLEX™) on, take off the cover and carefully change the magnet from
maintenance screen.
Select the protocol for the extraction from home screen, in our case protocol is MagMAX Pathogen
High Vol Duo and start the program. Place the plates according to the instruction displayed on the
screen and run the program. Note: It’s a 31 min protocol after program has started.
When program ends seal the Elution Plate carefully and store at +40C if concentration is measured in
same day or next day. Note: If concentration will not be measured next day, store the plate in -
200C. Measure the concentration and store the samples in same plate or transfer the samples into other
96 well plate or strips and store in -200C.
Protocol continues to next page
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H. Wash buffers Preparation
Prepare wash buffer 1 with Unautoclaved reagents
HWI_E For 100 ml
Stock Final Volume (ml)
Na-acetate pH 5.2 3M 0.3M 10
EDTA 0.5M 10mM 2
Carefully maintain pH 7.5 to 8.0 using 10M NaOH (~3ml required, pH might jump after
adding >2ml NaOH)
Send to autoclave and carefully adjust final volume (100 ml) by adding 70% EtOH)
Wash Buffer II (Prepare with autoclaved Tris-HCl)
HWII For 100 ml
Stock Final Volume (ml)
Tris-HCl (From
Stock prepared for
LYSIS buffer)-
1M 10mM 1
Ethanol 96 % 70 % 99
Total 100
Protocol ends here
